REG-Preliminary Results for the twelve months ended 31 January 2025
08/05/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250508:nGNE7MkKbS&default-theme=true
ICG Enterprise Trust plc Preliminary Results for the twelve months ended 31 January 2025 8 May 2025
Highlights * Actively-managed Portfolio focused on global mid-market private companies generating resilient growth
* NAV per Share reaches 2,073p; NAV per Share Total Return* of 10.5% during the year and five-year annualised return of 14.5%
* Portfolio Return* on a Sterling basis of 10.6%; portfolio companies reporting ~15% LTM earnings growth (1)
* 40 Full Exits executed at a weighted-average Uplift to Carrying Value of 19.0%
* Shareholder-focused capital allocation policy: £59m (5% of opening NAV) returned to shareholders in FY25 (2)(FY24: £35m), of which £36m through buybacks (FY24: £13m) and £23m through dividends of 36p per share (FY24: £22m, 33p per share)
* Wide range of potential outcomes to market transaction activity; secondaries market could present compelling opportunities
* Sector positioning, strong origination network and robust balance sheet position us well in current environment
* Post period-end, announced an additional £107m proceeds from a secondary sale and the realisation of Minimax (largest portfolio company, 3.1% of Portfolio at 31 January 2025)
1 EBITDA, based on Enlarged Perimeter covering 67% of the Portfolio 2 Based on dividends declared or proposed for Q1 FY25 – Q4 FY25 inclusive, and buybacks up to and including 31 January 2025 *This is an Alternative Performance Measure. Please refer to the Glossary for the definition.
Jane Tufnell Oliver Gardey
Chair of ICG Enterprise Trust Portfolio Manager for ICG Enterprise Trust
Today's results demonstrate that our investment strategy can Our portfolio companies are delivering solid operational performance (15% earnings growth LTM (1)). Our resilient Portfolio and robust balance sheet position us well for the current market environment. Our active approach to portfolio management is a differentiator for ICGT. As well as making a number of new commitments and investments during the year, we executed a secondary sale post period-end at a 5.5% discount that generated net cash proceeds of £62m for ICGT. The investment trust structure enables shareholders to invest efficiently in privately-owned companies. With our track record and network, ICGT is an attractive proposition for those seeking exposure to mature,
deliver long-term value. Our portfolio companies grew earnings profitable, cash-generative businesses.
by 15% in the year (1), and ICGT generated NAV per Share Total
Return of 10.5%, ending the year with NAV per Share of 2,073p.
During the year, the Board and Manager have been careful in
allocating our shareholders' capital. New investments continued,
deploying £181m and making commitments of £83m. Alongside this,
we returned £59m of cash to shareholders (5% of our opening NAV)
through buybacks and dividends. As we enter another period of
uncertainty, I am confident our long-term approach can generate
value for our shareholders, and I thank you for your continued
support.
PERFORMANCE OVERVIEW
Annualised
Performance to 31 January 2025 3 months 6 months 1 year 3 years 5 years 10 years
Portfolio Return on a Local Currency Basis 2.9% 6.2% 10.2% 8.9% 15.8% 15.3%
NAV per Share Total Return 4.3% 7.4% 10.5% 8.9% 14.5% 13.8%
Share Price Total Return 9.7% 1.5% 12.5% 6.6% 9.6% 11.8%
FTSE All-Share Index Total Return 6.9% 4.3% 17.1% 7.9% 6.6% 6.5%
Financial year ended: Jan 2021 Jan 2022 Jan 2023 Jan 2024 Jan 2025
Fund performance Portfolio return (local currency) 24.9% 24.4% 10.5% 5.9% 10.2%
Portfolio return (sterling) 26.4% 27.6% 17.0% 3.2% 10.6%
NAV £952m £1,158m £1,301m £1,283m £1,332m
NAV per Share Total Return (%) 22.5% 24.4% 14.5% 2.1% 10.5%
Investment activity New Investments £139m £304m £287m £137m £181m
As % opening Portfolio 17% 32% 24% 10% 13%
Realisation Proceeds £137m £334m £252m £171m £151m
As % opening Portfolio 17% 35% 21% 12% 11%
Shareholder experience Closing share price 966p 1,200p 1,150p 1,226p 1,342p
Total dividends per share 24p 27p 30p 33p 36p
Share Price Total Return 2.8% 27.1% (2.3)% 9.6% 12.5%
Total shareholder distributions £17m £21m £22m £35m £59m
As % Realisation Proceeds 12% 6% 9% 20% 39%
- o/w distributions dividends (%) 94% 86% 91% 63% 38%
- o/w distributions buybacks (%) 6% 14% 9% 37% 62%
Portfolio activity overview for FY25 Primary Direct Secondary Total ICG-managed
Local Currency return 8.2% 16.3% 6.4% 10.2% 8.4%
Sterling return 8.2% 17.0% 7.3% 10.6% 8.8%
New Investments £115m £58m £8m £181m £21m
Total Proceeds £101m £13m £37m £151m £60m
New Fund Commitments £64m - £20m £83m £20m
Closing Portfolio value £789m £507m £228m £1,523m £433m
% Total Portfolio 52% 33% 15% 100% 28%
COMPANY TIMETABLE
A presentation for investors and analysts will be held at 11:00 BST today. A
link to the presentation can be found on the Results & Reports page
(https://www.globenewswire.com/Tracker?data=Ug4cVKPm1a0rtTt80GBiiFnNF6cfCvKjDe3ODHvixkRMmIh6hOMD-gUgSt1fnbhZ3IG2PhaTf2g45daa-BScIKdK92zg-tJs1QlxKl3ddZy2gK-ac91S_VpJ3e5pcxcokZxbxHftkaTqOhUe9eYqKWd3bPTaGTEBmGJ5OgLeTdw=)
of the Company website. A recording of the presentation will be made available
on the Company website after the event.
FY25 Final Dividend
Ex-dividend date 3 July 2025
Record date 4 July 2025
Dividend payment date 18 July 2025
Annual General Meeting The Annual General Meeting will be held on Tuesday 24 June 2025. The Board will be communicating the format of the meeting separately in the Notice of Meeting. This will include details of how shareholders may register their interest in attending the Annual General Meeting. Shareholder Seminar We will be holding a Shareholder Seminar for institutional shareholders and research analysts at 3:30pm BST on Wednesday 18 June 2025, with registration starting at 3:15pm BST. Shareholders should contact icg-enterprise@icgam.com
should they wish to attend. Please note that for regulatory reasons this event is only open to institutional investors and research analysts.
ENQUIRIES
Institutional investors and analysts:
Martin Li, Shareholder Relations, ICG +44 (0) 20 3545 1816
Nathan Brown, Deutsche Numis +44 (0) 20 7260 1426
David Harris, Cadarn Capital +44 (0) 20 7019 9042
Media:
Clare Glynn, Corporate Communications, ICG +44 (0) 20 3545 1395
ABOUT ICG ENTERPRISE TRUST
ICG Enterprise Trust is a leading listed private equity investor focused on
creating long-term growth by delivering consistently strong returns through
selectively investing in profitable, cash-generative private companies,
primarily in Europe and the US, while offering the added benefit to
shareholders of daily liquidity.
We invest in companies directly as well as through funds managed by ICG plc
and other leading private equity managers who focus on creating long-term
value and building sustainable growth through active management and strategic
change.
NOTES
Included in this document are Alternative Performance Measures (“APMs”).
APMs have been used if considered by the Board and the Manager to be the most
relevant basis for shareholders in assessing the overall performance of the
Company, and for comparing the performance of the Company to its peers and its
previously reported results. The Glossary includes further details of APMs and
reconciliations to International Financial Reporting Standards (“IFRS”)
measures, where appropriate.
In the Manager’s Review and Supplementary Information, all performance
figures are stated on a Total Return basis (i.e. including the effect of
re-invested dividends). ICG Alternative Investment Limited, a regulated
subsidiary of Intermediate Capital Group plc, acts as the Manager of the
Company.
DISCLAIMER
The information contained herein and on the pages that follow does not
constitute an offer to sell, or the solicitation of an offer to acquire or
subscribe for, any securities in any jurisdiction where such an offer or
solicitation is unlawful or would impose any unfulfilled registration,
qualification, publication or approval requirements on ICG Enterprise Trust
PLC (the "Company") or its affiliates or agents. Equity securities in the
Company have not been and will not be registered under the applicable
securities laws of the United States, Australia, Canada, Japan or South Africa
(each an “Excluded Jurisdiction”). The equity securities in the Company
referred to herein and on the pages that follow may not be offered or sold
within an Excluded Jurisdiction, or to any U.S. person ("U.S. Person") as
defined in Regulation S under the U.S. Securities Act of 1933, as amended (the
"U.S. Securities Act"), or to any national, resident or citizen of an Excluded
Jurisdiction.
The information on the pages that follow may contain forward looking
statements. Any statement other than a statement of historical fact is a
forward looking statement. Actual results may differ materially from those
expressed or implied by any forward looking statement. The Company does not
undertake any obligation to update or revise any forward looking statements.
You should not place undue reliance on any forward looking statement, which
speaks only as of the date of its issuance.
CHAIR’S STATEMENT
Dear fellow shareholders,
For the 12 months to 31 January 2025 ICG Enterprise Trust delivered a NAV per
Share Total Return of 10.5% and a Share Price Total Return of 12.5%. Over the
last five years, the annualised returns have been 14.5% and 9.6% respectively.
The Board has declared dividends for the year of 36p (+9% compared to FY24)
and reduced ICGT’s share count by 4.3% during the year by returning £36m to
shareholders through share buybacks at a weighted average discount of 36.6%.
INVESTMENT STRATEGY
The Company’s Portfolio grew 10.2% on a Local Currency Basis during the year
(last five years annualised: 15.8%).
We invest in resilient private companies and are geographically balanced
between North America and Europe. During the year we evolved our target
portfolio mix towards having more Direct and Secondary Investments, which will
help to optimise Portfolio concentration and liquidity.
COST BASE
ICGT’s ongoing charges for FY25 were 1.38% (FY24: 1.37%). As a Board, we are
committed to providing value for our shareholders and transparent disclosure
around our cost. The change in fees and cost savings instigated by the Board
in FY24 continued to enhance the net return of our investment strategy
delivering £2.0m savings in FY25. We publish a Statement of Expenses that
sets out the impact of ICGT’s expenses on the financial returns to
shareholders (available at www.icg-enterprise.co.uk/soe) and which has been
updated for our FY25 expenses.
CAPITAL ALLOCATION
The Board has continued its proactive approach to capital allocation. We
balance the potential long-term compounding returns of investments into new
portfolio companies with cash returns to shareholders at par via dividends and
the value accretion of buying back shares at a discount to NAV. ICGT was the
first in our sector to introduce a long-term share buyback programme in FY23,
and in FY25 we supplemented this with an opportunistic buyback that has been
renewed for FY26.
Over the last five years, ICGT’s dividend per share has grown at an
annualised rate of 9.4% (including the proposed 10.5p final dividend being
declared for FY25). The ICGT ordinary dividend per share has now increased for
the twelfth consecutive year.
Since October 2022 our share buybacks have returned £51m to shareholders and
acquired shares at a weighted-average discount of 37.5%, increasing NAV per
Share by 54p (2.7%). We believe the share buybacks have also increased the
liquidity and reduced the volatility of our shares.
BALANCE SHEET
We continue to implement our objective of being fully invested through cycles
alongside maintaining a robust balance sheet. This allows us to manage our
resources in line with our capital allocation policy.
Having increased our credit facility during the year from €240m to €300m,
at 31 January 2025 ICG Enterprise Trust had total available liquidity of
£125m and net gearing of 10%. We have announced two transactions post
period-end that in aggregate generated Total Proceeds to ICGT of over £100m.
SALES AND MARKETING
In aggregate across the Board and Manager we own in excess of 270,000 shares,
and are aligned to the success of an investment in ICG Enterprise Trust
shares.
ICGT’s discount remains at levels that the Board feels do not reflect the
fundamental value of the shares. The discount is currently 41%. We continue to
be challenged by the share price trading at such a discount to NAV and the
Board is active in its pursuit of ways to improve the Company’s rating.
I had a year of strong shareholder engagement, welcomed several new holders to
our register and received valuable feedback that has been shared with the
Board and Manager. In conjunction with our Manager, our Corporate Broker and
our distribution partner we will continue the programme to help the market
understand ICGT’s shareholder proposition and its role within investment
portfolios.
OUTLOOK
Our focus on investing in private equity-owned companies that have resilient
growth characteristics gives shareholders access to investments that they
cannot reach through public market strategies. ICGT plays a valuable role in
our shareholders’ portfolios.
I believe there is substantial value in our Portfolio and in the new
investments the Manager is making on our shareholders’ behalf. Our Portfolio
is performing well, and I thank all shareholders for your continued support.
Jane Tufnell
Chair
7 May 2025
MANAGER’S REVIEW
Alternative Performance Measures
The Board and the Manager monitor the financial performance of the Company on
the basis of Alternative Performance Measures (‘APM’), which are
non-UK-adopted IAS (‘IAS’) measures. The APM predominantly form the basis
of the financial measures discussed in this review, which the Board believes
assists shareholders in assessing their investment and the delivery of the
investment strategy.
The Company holds certain investments in subsidiary entities. The substantive
difference between APM and IAS is the treatment of the assets and liabilities
of these subsidiaries. The APM basis ‘looks through’ these subsidiaries to
the underlying assets and liabilities they hold, and it reports the
investments as the Portfolio APM, gross of the liability in respect of the
Co-investment Incentive Scheme. Under IAS, the Company and its subsidiaries
are reported separately. The assets and liabilities of the subsidiaries, which
include the liability in respect of the Co-investment Incentive Scheme, are
presented on the face of the IAS balance sheet as a single carrying value. The
same is true for the IAS and APM basis of the cash flow statement.
The following table sets out IAS metrics and the APM equivalents:
IFRS (£m) 31 January 2025 31 January 2024 APM (£m) 31 January 2025 31 January 2024
Investments 1,470 1,296 Portfolio 1,523 1,349
NAV 1,332 1,283 Realisation Proceeds 151 171
Cash flows from the sale of portfolio investments 20 41 Total Proceeds 151 239
Cash flows related to the purchase of portfolio investments 34 25 Total New Investment 181 137
The Glossary includes definitions for all APM and, where appropriate, a
reconciliation between APM and IAS.
Why private equity
Every day the lives of those living and working in the US and Western Europe
are touched by companies owned by private equity: retailers, payments
processors, home security, pet food, health services – the list is long.
What typically unites these businesses is that they are profitable and cash
generative. These businesses are actively managed by their shareholders, with
management teams heavily incentivised to generate returns. Increasingly
companies with these characteristics are choosing to grow under private equity
ownership and to stay private for longer. Within that, ICGT focuses on a
subset of those companies that we expect will generate resilient growth. As
more businesses are owned by private equity, we believe it is a structurally
attractive allocation within an investment portfolio, with a track record of
attractive returns, and significant opportunity to continue that trajectory.
A share in ICGT gives you access to a unique portfolio of private companies.
Our investment strategy
Within developed markets, we focus on investing in buyouts of profitable,
cash-generative businesses that exhibit resilient growth characteristics,
which we believe will generate strong long-term compounding returns across
economic cycles.
We take an active approach to Portfolio construction, with a flexible mandate
that enables us to deploy capital in Primary, Secondary and Direct
Investments. Geographically, we focus on the developed markets of North
America and Europe which have deep and mature private equity markets.
Medium-term target Five-year average 31 January 2025
1. Target Portfolio composition (1)
Investment category
Primary ~40-50% 57% 52%
Direct ~30-35% 28% 33%
Secondary ~25-30% 15% 15%
Geography (2)
North America ~50% 40% 46%
Europe (inc. UK) ~50% 52% 48%
Other — 8% 6%
2. Balance sheet
Net cash/(Net Debt) (3) ~0% (1)% (10)%
1. Five-year average is the linear average of FY exposures for FY21-FY25.
2. As a percentage of Portfolio.
3. (Net cash)/debt as a percentage of NAV. Post period-end, we announced Total Proceeds of over £100m from a secondary sale and the realisation of Minimax, see page 14
ICG Enterprise Trust benefits from access to ICG-managed funds and Direct
Investments, which represented 28% of the Portfolio value at period end and
generated a 8.4% return on a Local Currency Basis.
Performance overview
At 31 January 2025, our Portfolio was valued at £1,523m, and the Portfolio
Return on a Local Currency Basis for the financial year was 10.2% (FY24:
5.9%).
Due to the geographic diversification of our Portfolio, the reported value is
impacted by changes in foreign exchange rates. During the period, FX movements
affected the Portfolio positively by £5.4m, driven by US dollar appreciation.
In sterling terms, Portfolio growth during the period was 10.6%.
The net result for shareholders was that ICG Enterprise Trust generated a NAV
per Share Total Return of 10.5% during FY25, ending the period with a NAV per
Share of 2,073p.
Movement in the Portfolio £m Twelve months to 31 January 2025 Twelve months to 31 January 2024
Opening Portfolio (1) 1,349 1,406
Total New Investments 181 137
Total Proceeds (151) (239)
Portfolio net cashflow 30 (102)
Valuation movement (2) 138 83
Currency movement 6 (39)
Closing Portfolio 1,523 1,349
1. Refer to the Glossary. 2. 97% of the Portfolio is valued using 31 December 2024 (or later) valuations (FY24: 94%).
NAV per Share Total Return Twelve months to 31 January 2025 Twelve months to 31 January 2024
% Portfolio growth (local currency) 10.2% 5.9%
% currency movement 0.4% (2.7%)
% Portfolio growth (Sterling) 10.6% 3.2%
Impact of gearing 0.7% (0.3)%
Finance costs and other expenses (0.6)% (0.2)%
Management fee (1.3)% (1.2)%
Co-investment Incentive Scheme Accrual (0.7)% (0.1)%
Impact of share buybacks 1.8% 0.7%
NAV per Share Total Return 10.5% 2.1%
For Q4 the Portfolio Return on a Local Currency Basis was 2.9% and the NAV per
Share Total Return was 4.3%
Executing our investment strategy
Commitments in the financial year Total New Investments in the financial year Growth in the financial year Total Proceeds in the financial year
Making commitments to funds, which expect to be drawn over 3 to 5 years Cash deployments into portfolio companies, either through funds or directly Driving growth and value creation of our portfolio companies Cash realisations of investments in Portfolio companies, plus Fund Disposals
£83m (FY24: £153m) £ 181 m (FY24: £137m) £ 138 m (FY24: £83m) £ 151 m (FY24: £239m)
Commitments
Our evergreen structure and flexible investment mandate enable us to commit
through the cycle, maintaining vintage diversification for our Portfolio and
sowing the seeds for future growth.
During the year we made 7 new Fund Commitments totalling £83.4m, including
£19.8m to funds managed by ICG plc, as detailed below:
Fund Manager Commitment during the period
Local currency £m
ICG Strategic Equity V ICG $25.0 m £19.8 m
Leeds VIII Leeds Equity $20.0 m £15.7 m
Investindustrial VIII Investindustrial €15.0 m £12.9 m
Oak Hill VI Oak Hill $15.0 m £11.9 m
Thoma Bravo XVI Thoma Bravo $15.0 m £11.7 m
Valeas I Valeas $10.0 m £7.5 m
American Securities IX American Securities $5.0 m £4.0 m
At 31 January 2025, ICG Enterprise Trust had outstanding Undrawn Commitments
of £553.2m
Movement in outstanding Commitments Year to 31 January 2025 £m
Undrawn Commitments as at 1 February 2024 552.0
New Fund Commitments 83.4
New Commitments relating to Direct Investments 65.3
Total New Investments (181.4)
Currency and other movements 33.9
Undrawn commitments as at 31 January 2025 553.2
Total Undrawn Commitments at 31 January 2025 comprised £419.1m of Undrawn
Commitments to funds within their Investment Period, and a further £134.1m
was to funds outside their Investment Period.
31 January 2025 £m 31 January 2024 £m
Undrawn Commitments – funds in Investment Period 419.1 434.2
Undrawn Commitments – funds outside Investment Period 134.1 117.7
Total Undrawn Commitments 553.2 552.0
Total available liquidity (including debt facility) (124.6) (195.9)
Overcommitment net of total available liquidity 428.6 356.1
Overcommitment % of net asset value 31.1% 27.7%
Commitments are made in the funds’ underlying currencies. The currency split
of the Undrawn Commitments at 31 January 2025 was as follows:
31 January 2025 31 January 2024
Undrawn Commitments £m % £m %
US Dollar 310.3 56.1% 290 52.5%
Euro 213.1 38.5% 236 42.7%
Sterling 29.8 5.4% 26 4.8%
Total 553.2 100.0% 552.0 100.0%
Investments
Total new investments of £181.4m during the period, of which 12% (£21.1m)
were alongside ICG. New investment by category detailed in the table below:
Investment Category Cost (£m) % of New Investments
Primary 115.5 63.6%
Direct 58.4 32.2%
Secondary 7.6 4.2%
Total 181.4 100.0%
The five largest new investments in the period were as follows:
Investment Description Manager Country Cost £m (1)
Datasite Provider of software focused on virtual data rooms ICG United States 18.4
Visma Provider of business management software and outsourcing services Hg Norway 14.5
Audiotonix Manufacturer of audio mixing consoles PAI United Kingdom 14.0
Multiversity Provider of online higher education courses. ICG/CVC Italy 9.4
Avid Bioservices Provider of biologics development and manufacturing services GHO United States 7.3
Top 5 largest underlying new investments 63.6
1 Represents ICG Enterprise Trust’s indirect investment (share of fund cost)
plus any Direct Investments in the period.
Occasionally ICGT simultaneously has both a realisation from and an investment
into the same company in the same period. This typically occurs when an
underlying fund sells a company that is purchased by another fund within
ICGT’s portfolio. During FY25 shareholders will note that Datasite and Visma
appear both in the top 5 realisations and top 5 new investments, which is a
result of this situation.
GROWTH
The Portfolio grew by £138.0m (+10.2%) on a Local Currency Basis in the 12
months to 31 January 2025.
Growth across the Portfolio was split as follows:
* By investment type: growth was spread across Primary (8.2%), Secondary
(6.4%) and Direct (16.3%)
* By geography: North America and Europe experienced growth of 12.1% and 8.4%
respectively
The growth in the Portfolio is underpinned by the performance of our portfolio
companies, which delivered robust financial performance during the period:
Top 30 Enlarged Perimeter
Portfolio coverage 41% 67%
Last Twelve Months ('LTM') revenue growth 9.0% 11.2%
LTM EBITDA growth 15.5% 15.3%
Net Debt / EBITDA 4.0x 4.4x
Enterprise Value / EBITDA 15.4x 15.2x
Note: values are weighted averages for the respective portfolio segment; see Glossary for definition and calculation methodology
QUOTED COMPANY EXPOSURE
We do not actively invest in publicly quoted companies but gain listed
investment exposure when IPOs are used as a route to exit an investment. In
these cases, exit timing typically lies with the manager with whom we have
invested.
At 31 January 2025, ICG Enterprise Trust’s exposure to quoted companies was
valued at £73.1m, equivalent to 4.8% of the Portfolio value (31 January 2024:
4.8%). Across the Portfolio, quoted positions resulted in a £4.3m increase in
Portfolio NAV during the period. The share price of our largest listed
exposure, Chewy, increased by 119% in local currency (USD) during the period.
This positively impacted the Portfolio Return on a Local Currency Basis by
approximately 0.8%.
At 31 January 2025 Chewy was the only quoted investment that individually
accounted for 0.5% or more of the Portfolio value:
Company Ticker 31 January 2025 % of Portfolio value
Chewy CHWY-US 2.0%
Other companies 2.8%
Total 4.8%
REALISATIONS
During FY25, the ICG Enterprise Trust Portfolio generated Total Proceeds of
£150.8m.
Realisation activity during the period included 40 Full Exits generating
proceeds of £73.7m. These were completed at a weighted average Uplift to
Carrying Value of 19% and represent a weighted average Multiple to Cost of
2.9x for those investments.
Realisation Manager Description Country Proceeds £m
VettaFi ICG Provider of master limited partnerships ("MLP") indices United States 10.2
Visma ICG Provider of business management software and outsourcing services Norway 8.2
Datasite ICG Provider of software focused on virtual data rooms United States 7.8
Compass Community Graphite Provider of fostering services and children residential care United Kingdom 7.4
IRIS ICG Provider of software and services for the accountancy and payroll sectors United Kingdom 7.0
Total of 5 largest underlying realisations 40.7
Balance sheet and liquidity
Net assets at 31 January 2025 were £1,332m, equal to 2,073p
per share.
The Company had net debt of £128m and at 31 January 2025, the Portfolio
represented 114% of net assets (31 January 2024: 105%).
£m % of net assets
Portfolio 1,523.1 114.3%
Cash 3.9 0.3%
Drawn debt (131.9) (9.9)%
Co-investment Incentive Scheme Accrual (53.9) (4.0)%
Other net current liabilities (8.8) (0.7)%
Net assets 1,332.4 100.0%
Our objective is to be fully invested through the cycle, while ensuring that
we have sufficient financial resources to be able to take advantage of
attractive investment opportunities as they arise.
During the year, our balance sheet flexibility was enhanced through an
increase in the credit facility size from €240m to €300m. This change was
effective from 20 December 2024.
At 31 January 2025, ICG Enterprise Trust had a cash balance
of £3.9m (31 January 2024: £11.2m) and total available liquidity of £124.6m
(31 January 2024: £195.9m).
£m
Cash at 31 January 2024 11.2
Total Proceeds 150.8
New investments (181.4)
Debt drawn down 111.9
Shareholder returns (58.2)
Management fees (16.0)
FX and other expenses (13.5)
Cash at 31 January 2025 3.9
Available undrawn debt facilities 120.7
Total available liquidity 124.6
Dividend and share buyback
ICG Enterprise Trust has a progressive dividend policy alongside two share
buyback programmes to return capital to shareholders.
DIVIDENDS
The Board has declared a dividend of 10.5p per share in respect of the fourth
quarter, taking total dividends for the year to 36p (FY24: 33p). It is the
twelfth consecutive year of ordinary dividend per share increases.
SHARE BUYBACKS
The following purchases have been made under the Company's share buyback
programmes:
Long-term Opportunistic Total
FY25 (3) Since inception (1) FY25 (3) Since inception (2) FY25 (3) Since inception
Number of shares purchased 1,420,500 2,752,688 1,492,175 1,492,175 2,912,675 4,244,863
% of opening shares since buyback started 4.3% 6.2%
Capital returned to shareholders £17.3m £32.6m £18.3m £18.3m £35.6m £50.8m
Number of days shares have been acquired 87 183 11 11 98 194
Weighted average discount to last reported NAV 37.0% 38.3% 36.2% 36.2% 36.6% 37.5%
NAV per Share accretion (p) 36.5 54.1
NAV per Share accretion (% of NAV) 1.8% 2.7%
1.Since October 2022 (which was when the long-term share buyback programme was
launched) up to and including 31 January 2025.
2. Since May 2024 (which was when the opportunistic buyback programme was
launched) up to and including 31 January 2025.
3. Based on company-issued announcements / date of purchase, rather than date
of settlement.
Note: aggregate consideration excludes commission, PTM and SDRT.
The Board believes the long-term buyback programme demonstrates the
Manager’s discipline around capital allocation; underlines the Board’s
confidence in the long-term prospects of the Company, its cash flows and NAV;
will enhance the NAV per Share; and, over time, may positively influence the
volatility of the Company’s discount and its trading liquidity.
During the period, the Board announced an opportunistic share buyback
programme for FY25 of up to £25m. This is intended to enable us to take
advantage of current trading levels, when the ability to purchase shares in
meaningful size at a significant discount presents itself. It was renewed for
FY26 for an additional year up to £25m.
Foreign exchange rates
The details of relevant foreign exchange rates applied in this report are
provided in the table below:
Average rate for FY25 Average rate for FY24 31 January 2025 year end 31 January 2024 year end
GBP:EUR 1.18 1.15 1.20 1.17
GBP:USD 1.28 1.25 1.24 1.27
EUR:USD 1.08 1.08 1.04 1.08
Activity since the period end
Notable activity between 1 February 2025 and 31 March 2025 has included:
* Four new Fund Commitments for a combined value of £64m
* New investments of £39m
* Realisation Proceeds of £26m
From 1 February 2025 up to and including 30 April 2025, 718,000 shares
(£8.9m) were bought back at a weighted-average discount to NAV of 37.9%.
In addition, during the month of April 2025, we announced that proceeds of
£107m were received as a result of two transactions:
* Secondary sale (£62m net proceeds), executed at a discount of 5.5% to 30
September 2024 valuation and realising a 1.6x return on invested cost (15%
IRR)
* Realisation of Minimax (€53m (£45m) proceeds), ICGT’s largest portfolio
company at 31 January 2025 (3.1% of Portfolio value). ICG Enterprise Trust is
reinvesting €10m in the next stage of Minimax’s growth alongside
Management and other investors including certain ICG funds.
ICG Private Equity Funds Investment Team
7 May 2025
SUPPLEMENTARY INFORMATION
This section presents supplementary information regarding the Portfolio (see
Manager’s Review and the Glossary for further details and definitions).
Portfolio composition
Portfolio by calendar year of investment % of value of underlying investments 31 January 2025 % of value of underlying investments 31 January 2024
2025 0.5% —%
2024 10.1% —%
2023 7.6% 6.9%
2022 18.5% 18.7%
2021 25.7% 27.9%
2020 8.6% 11.4%
2019 10.3% 12.4%
2018 7.3% 10.5%
2017 2.2% 4.2%
2016 and older 9.2% 8.0%
Total 100.0% 100.0%
Portfolio by sector % of value of underlying investments 31 January 2025 % of value of underlying investments 31 January 2024
TMT 29.9% 25.3%
Consumer goods and services 18.1% 17.5%
Healthcare 11.5% 11.3%
Business services 12.4% 13.1%
Industrials 7.8% 7.9%
Education 5.0% 7.4%
Financials 7.6% 5.7%
Leisure 4.0% 7.3%
Other 3.7% 4.5%
Total 100.0% 100.0%
Portfolio by fund currency (1) 31 January 2025 £m 31 January 2025 % 31 January 2024 £m 31 January 2024 %
US Dollar 796 52.3% 674 49.9%
Euro 584 38.4% 555 41.2%
Sterling 140 9.2% 120 8.9%
Total 1,523 1,349 100.0%
(1)Currency exposure by reference to the reporting currency of each fund .
Portfolio Dashboard
The tables below provide disclosure on the composition and dispersion of
financial and operational performance for the Top 30 and the Enlarged
Perimeter. At 31 January 2025, the Top 30 Companies represented 40.2% of the
Portfolio by value and the Enlarged Perimeter represented 66.9% of total
Portfolio value. This information is prepared on a value-weighted basis, based
on contribution to Portfolio value at 31 January 2025. Datasets for Top 30
companies and ‘Enlarged perimeter’ are not distinct and will have some
overlap.
% of value at 31 January 2025
Sector exposure Top 30 Enlarged Perimeter
TMT 17.3% 30.2%
Business services 16.9% 13.9%
Consumer goods and services 14.0% 17.3%
Industrials 27.3% 8.7%
Healthcare 8.4% 10.0%
Education 6.9% 6.5%
Leisure 6.8% 5.1%
Financials 2.4% 5.1%
Other —% 3.2%
Total 100.0% 100.0%
% of value at 31 January 2025
Geographic exposure (1) Top 30 Enlarged Perimeter
North America 43.6% 45.0%
Europe 50.3% 50.5%
Other 6.1% 4.5%
Total 100.0% 100.0%
1 Geographic exposure is calculated by reference to the location of the headquarters of the underlying Portfolio companies
% of value at 31 January 2025
LTM revenue growth Top 30 Enlarged Perimeter
<-10% 3.2% 4.0%
`-10-0% 9.0% 10.2%
0-10% 59.4% 47.0%
10-20% 15.2% 20.6%
20-30% 3.6% 5.6%
>30% 9.6% 10.0%
n.a. (1) —% 2.7%
Weighted average 9.0% 11.2%
Note: for consistency, any excluded investments are excluded for all dispersion analysis.
% of value at 31 January 2025
LTM EBITDA growth Top 30 Enlarged Perimeter
<-10% 5.8% 7.2%
`-10-0% 9.7% 10.3%
0-10% 31.4% 27.5%
10-20% 21.9% 23.0%
20-30% 7.2% 8.9%
>30% 24.0% 19.9%
n.a (1) —% 3.2%
Weighted average 15.5% 15.3%
Note: for consistency, any excluded investments are excluded for all dispersion analysis.
% of value at 31 January 2025
EV/EBITDA multiple Top 30 Enlarged Perimeter
0-10x 8.5% 10.4%
10-12x 17.2% 16.4%
12-13x 8.1% 7.8%
13-15x 18.6% 18.0%
15-17x 25.9% 21.7%
17-20x 6.5% 7.7%
>20x 15.2% 15.4%
n.a. (1) —% 2.6%
Weighted average 15.4x 15.2x
Note: for consistency, any excluded investments are excluded for all dispersion analysis.
% of value at 31 January 2025
Net Debt / EBITDA Top 30 Enlarged Perimeter
<2x 27.2% 17.3%
2-4x 17.3% 19.9%
4-5x 14.1% 15.7%
5-6x 6.7% 13.2%
6-7x 26.0% 17.8%
>7x 8.7% 11.2%
n.a. (1) —% 5.1%
Weighted average 4.0x 4.4x
Note: for consistency, any excluded investments are excluded for all dispersion analysis.
Top 30 companies
The table below presents the 30 companies in which ICG Enterprise Trust had
the largest investments by value at 31 January 2025. The valuations are gross
of underlying managers fees and carried interest.
Company Manager Year of investment Country Value as a % of Portfolio
1 Minimax
Supplier of fire protection systems and services ICG 2018 Germany 3.1%
2 Froneri
Manufacturer and distributor of ice cream products PAI 2013 / 2019 United Kingdom 2.5%
3 Chewy
Online retailer of premium pet food and products BC Partners 2022 United States 2.0%
4 Datasite
Provider of software focused on virtual data rooms ICG 2024 United States 1.9%
5 Leaf Home Solutions
Provider of home maintenance services Gridiron 2016 United States 1.6%
6 Visma
Provider of business management software and outsourcing services Hg/ICG 2024 Norway 1.6%
7 Circana
Provider of mission-critical data and predictive analytics to consumer goods manufacturers New Mountain 2022 United States 1.6%
8 European Camping Group
Operator of premium campsites and holiday parks PAI 2021 / 2023 France 1.5%
9 Davies Group
Provider of speciality business process outsourcing services BC Partners 2021 United Kingdom 1.5%
10 Ambassador Theatre Group
Operator of theatres and ticketing platforms ICG 2021 United Kingdom 1.4%
11 Precisely
Provider of enterprise software Clearlake/ICG 2021 / 2022 United States 1.3%
12 Newton
Provider of management consulting services ICG 2021 / 2022 United Kingdom 1.3%
13 David Lloyd Leisure
Operator of premium health clubs TDR 2013 / 2020 United Kingdom 1.3%
14 Curium Pharma
Supplier of nuclear medicine diagnostic pharmaceuticals ICG 2020 United Kingdom 1.3%
15 PSB Academy
Provider of private tertiary education ICG 2018 Singapore 1.3%
16 Crucial Learning
Provider of corporate training courses focused on communication skills and leadership development Leeds Equity 2019 United States 1.3%
17 Class Valuation
Provider of residential mortgage appraisal management services Gridiron 2021 United States 1.3%
18 Domus
Operator of retirement homes ICG 2017 / 2021 France 1.2%
19 Yudo
Designer and manufacturer of hot runner systems ICG 2017 / 2018 South Korea 1.2%
20 ECA Group
Provider of autonomous systems for the aerospace and maritime sectors ICG 2022 France 1.1%
21 Brooks Automation
Provider of semiconductor manufacturing solutions THL 2021 / 2022 United States 1.0%
22 Planet Payment
Provider of integrated payments services focused on hospitality and luxury retail Advent/Eurazeo/ICG 2021 Ireland 1.0%
23 Ivanti
Provider of IT management solutions Charlesbank/ICG 2021 United States 1.0%
24 Vistage
Provider of CEO leadership and coaching for small and mid-size businesses in the US Gridiron 2022 United States 1.0%
25 Audiotonix
Manufacturer of audio mixing consoles PAI 2024 United Kingdom 0.9%
26 DigiCert
Provider of enterprise security solutions ICG 2021 United States 0.9%
27 Ping Identity
Provider of intelligent access management solutions Thoma Bravo 2022 / 2023 United States 0.9%
28 KronosNet
Provider of tech-enabled customer engagement and business solutions ICG 2022 Spain 0.8%
29 Archer Technologies
Provider of governance, risk and compliance software Cinven 2023 United States 0.7%
30 Silvus Technologies
Developer of mobile communications datalinks used in law enforcement, unmanned systems and other commercial/industrial applications TJC 2019 United States 0.7%
Total of the 30 largest underlying investments 40.2%
The 30 largest fund investments
The table below presents the 30 largest fund investments by value at 31
January 2025. The valuations are net of underlying managers’ fees and
carried interest.
Fund Year of commitment Value £m Outstanding commitment £m
1 PAI Strategic Partnerships **
Mid-market and large buyouts 2019 34.6 0.2
2 ICG Strategic Equities Fund IV
GP-led secondary transactions 2021 32.9 7.1
3 ICG Strategic Equities Fund III
GP-led secondary transactions 2018 31.0 11.2
4 ICG Europe VII
Mezzanine and equity in mid-market buyouts 2018 30.7 6.1
5 CVC European Equity Partners VII
Large buyouts 2017 25.7 2.9
6 PAI Europe VII
Mid-market and large buyouts 2017 24.6 2.4
7 ICG Ludgate Hill (Feeder B) SCSp
Secondary portfolio 2021 23.8 13.6
8 ICG Europe VIII
Mezzanine and equity in mid-market buy-outs 2021 23.6 14.3
9 Gridiron Capital Fund III
Mid-market buyouts 2016 23.4 1.3
10 Resolute IV
Mid-market buyouts 2018 23.0 0.9
11 Gridiron Capital Fund IV
Mid-market buyouts 2019 21.5 0.5
12 ICG Augusta Partners Co-Investor **
Secondary fund restructurings 2018 20.5 17.8
13 Oak Hill V
Mid-market buyouts 2019 19.9 0.6
14 Seventh Cinven
Large buyouts 2019 19.8 1.8
15 Graphite Capital Partners VIII *
Mid-market buyouts 2013 19.3 4.1
16 Graphite Capital Partners IX
Mid-market buyouts 2018 18.4 2.3
17 ICG Ludgate Hill III
Secondary portfolio 2022 18.0 5.7
18 Resolute V
Mid-market buyouts 2021 17.1 1.4
19 Advent Global Private Equity IX
Large buyouts 2019 16.4 0.5
20 ICG Ludgate Hill (Feeder) II Boston SCSp
Secondary portfolio 2022 16.0 5.4
21 New Mountain Partners VI
Mid-market buy-outs 2020 14.9 0.5
22 Investindustrial VII
Mid-market buyouts 2019 14.0 4.9
23 ICG Europe Mid-Market Fund
Mezzanine and equity in mid-market buyouts 2019 13.5 5.5
24 CVC Capital Partners VIII
Large buyouts 2020 13.4 0.5
25 Bowmark Capital Partners VI
Mid-market buyouts 2018 13.1 3.4
26 Tailwind Capital Partners III
Mid-market buyouts 2018 13.1 2.2
27 BC European Capital X
Large buyouts 2016 13.1 1.4
28 Thomas H Lee Equity Fund IX
Mid-market and large buyouts 2021 12.9 4.0
29 Permira VII
Large buyouts 2019 12.6 1.6
30 ICG LP Secondaries Fund I LP
LP-led secondary transactions 2022 12.2 41.1
Total of the largest 30 fund investments 593.0 165.3
Percentage of total investment Portfolio 39.1%
*All or part of interest acquired through a secondary sale.
**Includes the associated Top Up funds.
HOW WE MANAGE RISK
Identifying and evaluating the strategic, financial and operational impact of
our key risks
The execution of the Company’s investment strategy is subject to a variety
of risks and uncertainties, and the Board and Manager have identified several
principal risks to the Company’s business. As part of this process, the
Board has put in place an ongoing process to identify, assess and monitor the
principal and emerging risks facing the Company, including those that would
threaten its business model, future performance, solvency or liquidity.
RISK MANAGEMENT FRAMEWORK
The Board is responsible for risk management and determining the Company’s
overall risk appetite. The Audit Committee assesses and monitors the risk
management framework and specifically reviews the controls and assurance
programmes in place.
PRINCIPAL RISKS
The Company’s principal risks are individual risks, or a combination of
risks, that could threaten the Company’s business model, future performance,
solvency or liquidity.
Details of the Company’s principal risks, potential impact, controls and
mitigating factors are set out on pages 23 to 27.
OTHER RISKS
Other risks, including reputational risk, are potential outcomes of the
principal risks materialising. These risks are actively managed and mitigated
as part of the wider risk management framework of the Company and the Manager.
EMERGING RISKS
Emerging risks are considered by the Board and are regularly assessed to
identify any potential impact on the Company and to determine whether any
actions are required. Emerging risks often include those related to
regulatory/legislative change and macro-economic and political change.
The Company depends upon the experience, skill and reputation of the employees
of the Manager. The Manager’s ability to retain the service of these
individuals, who are not obligated to remain employed by the Manager, and
recruit successfully, is a significant factor in the success of the Company.
PRINCIPAL RISKS AND UNCERTAINTIES
The Company considers its principal risks (as well as several underlying risks
comprising each principal risk) in four categories:
1. Investment risks: the risk to performance resulting from ineffective or
inappropriate investment selection, execution or monitoring.
2. External risks: the risk of failing to deliver the Company’s investment
objective and strategic goals due to external factors beyond the Company’s
control.
3. Operational risks: the risk of loss resulting from inadequate or failed
internal processes, people or systems and external events, including
regulatory risk.
4. Financial risks: the risk of adverse impact on the Company due to having
insufficient resources to meet its obligations or counterparty failure and the
impact any material movement in foreign exchange rates may have on underlying
valuations.
RISK ASSESSMENT PROCESS
A comprehensive risk assessment process is undertaken regularly to re-evaluate
the impact and probability of each risk materialising and the strategic,
financial and operational impact of the risk. Where the residual risk is
determined to be outside appetite, appropriate action is taken. Further
information on risk factors is set out within the financial statements.
Risk appetite and tolerance
The Board acknowledges and recognises that in the normal course of business,
the Company is exposed to risk and it is willing to accept a certain level of
risk in managing the business to achieve its targeted returns. The Board’s
risk appetite framework provides a basis for the ongoing monitoring of risks
and enables dialogue with respect to the Company’s current and evolving risk
profile, allowing strategic and financial decisions to be made on an informed
basis.
The Board considers several factors to determine its acceptance for each
principal risk and categorises acceptance for each risk as low, moderate and
high. Where a risk is approaching or is outside the tolerance set, the Board
will consider the appropriateness of actions being taken to manage the risk.
In particular, the Board has a lower tolerance for financing risk with the aim
to ensure that even under a stress scenario, the Company is likely to meet its
funding requirements and financial obligations. Similarly, the Board has a low
risk tolerance concerning operational risks including legal, tax and
regulatory compliance and business process and continuity risk.
How we manage and mitigate our key risks
RISK IMPACT MITIGATION CHANGE IN THE YEAR
INVESTMENT RISKS
INVESTMENT PERFORMANCE The Manager selects the fund investments and Direct Investments for the Company’s Portfolio, executing the investment strategy approved by the Board. The underlying managers of those funds in turn select individual investee companies. The origination, investment selection and management capabilities of both the Manager and the third-party managers are key to the performance of the Company. Poor origination, investment selection and monitoring by the Manager and/or third-party managers which may have a negative impact on Portfolio performance. The Manager has a strong track record of investing in private equity through multiple economic cycles. The Manager has a highly Stable The Board is responsible for ensuring that the investment policy is met. The day-to-day management of the Company’s assets is delegated to the Manager under investment guidelines determined by the Board. The Board regularly reviews these guidelines to ensure they remain appropriate and monitors compliance with the guidelines through regular reports from the Manager, including performance reporting. The Board also reviews the investment strategy at least annually. Following this assessment and other considerations, the Board concluded that investment performance risk has remained stable.
selective investment approach and disciplined process, which is overseen by ICG Enterprise Trust’s Investment Committee within
the Manager, which comprises a balance of skills and perspectives. Further, the Company’s Portfolio is diversified, reducing
the likelihood of a single investment decision impacting Portfolio performance.
VALUATION In valuing its investments in private equity funds and unquoted companies and publishing its NAV, the Company relies to a significant extent on the accuracy of financial and other information provided by the underlying managers to the Manager. There is the potential for inconsistency in the valuation methods adopted by the managers of these funds and companies and for valuations to be misstated. Incorrect valuations being provided would lead to an incorrect overall NAV. The Manager carries out a formal valuation process quarterly including a review of third-party valuations. This process Stable The Board regularly reviews and discusses the valuation process in detail with the Manager, including the sources of valuation information and methodologies used. Following this assessment and other considerations, the Board concluded that there was no material change in valuation risk.
includes a comparison of unaudited valuations to latest audited reports, as well as a review of any potential adjustments that
are required to ensure the valuations of the underlying investments are in accordance with the fair market value principles
required under UK-adopted International Accounting Standards (‘IAS’).
EXTERNAL RISKS
POLITICAL AND MACRO-ECONOMIC UNCERTAINTY Political and macro-economic uncertainty and other global events, such as pandemics, that are outside the Company’s control could adversely impact the environment in which the Company and its investment portfolio companies operate. Changes in the political or macro-economic environment could significantly affect the performance of existing investments (and valuations) and prospects for realisations. In addition, they could impact the number of credible investment opportunities the Company can originate. The Manager uses a range of complementary approaches to inform strategic planning and risk mitigation, including active Increasing The Board monitors and reviews the potential impact on the Company from political and economic developments on an ongoing basis, including input and discussions with the Manager. Incorporating these views and other considerations, the Board concluded that this risk had increased.
investment management, profitability and balance sheet scenario planning and stress testing to ensure resilience across a range
of outcomes. The process is supported by a dedicated in-house economist and professional advisers where appropriate.
CLIMATE CHANGE The underlying managers of the fund investments and Direct Investments in the Company’s Portfolio fail to ensure that their portfolio companies respond to the emerging threats from climate change. Climate-related transition risks, driven in particular by abrupt shifts in the political and technological landscape, impact the value of the Company’s Portfolio. The Manager has a well-defined, firm-wide Responsible Investing Policy and sustainable investing framework in place. A tailored Stable The Board monitors and reviews the potential impact to the Company from failures by underlying managers to mitigate the impact of climate change on portfolio company valuation.
sustainable investing framework applies across all stages of the Company’s investment process.
THE LISTED PRIVATE EQUITY SECTOR The listed private equity sector could fall out of favour with investors leading to a reduction in demand for the Company’s shares. A change in sentiment to the sector has the potential to damage the Company’s reputation and impact the performance of the Company’s share price and widen the discount the shares trade at relative to NAV per Share, causing shareholder dissatisfaction. Private equity continues to outperform public markets over the long term and has proved to be an attractive asset class through Increasing The persistence of the discount to NAV, together with other sector uncertainties, indicates an increase in risk. The Board receives regular updates from the Company’s broker and is kept informed of all material discussions with investors and analysts.
various cycles. The Manager is active in marketing the Company’s shares to a wide variety of investors to ensure the market is
informed about the Company’s performance and investment proposition. In setting the capital allocation policy, including the
allocations to dividends and share buybacks, the Board monitors the discount to NAV and considers appropriate solutions to
address any ongoing or substantial discount to NAV.
FOREIGN EXCHANGE The Company has continued to expand its geographic diversity by making investments in different countries. Accordingly, most investments are denominated in US dollars and euros. The Company does not hedge its foreign exchange exposure. Therefore, movements in exchange rates between these currencies may have a material effect on the underlying sterling valuations of the investments and performance of the Company. The Board regularly reviews the Company’s exposure to currency risk and reconsiders possible hedging strategies on at least an Stable The Board reviewed the Company’s exposure to currency risk and possible hedging strategies and concluded that there was no material change in foreign exchange risk during the year and that it remains appropriate for the Company not to hedge its foreign exchange exposure.
annual basis. Furthermore, the Company’s multicurrency bank facility permits the borrowings to be drawn in euros and US dollars,
if required.
OPERATIONAL RISKS
REGULATORY, LEGAL AND TAX COMPLIANCE Failure by the Manager to comply with relevant regulation and legislation could have an adverse impact on the Company. Additionally, adherence to changes in the legal, regulatory and tax framework applicable to the Manager could become onerous, lessening competitive or market opportunities. The failure of the Manager and the Company to comply with the rules of professional conduct and relevant laws and regulations could expose the Company to regulatory sanction and penalties as well as significant damage to its reputation. The Board is responsible for ensuring the Company’s compliance with all applicable regulatory, legal and tax requirements. Stable The Company remains responsive to a wide range of developing regulatory areas; and will continue to enhance its processes and controls in order to remain compliant with current and expected legislation.
Monitoring of this compliance has been delegated to the Manager, of which the in-house Legal, Compliance and Risk functions
provide regular updates to the Board covering relevant changes to regulation and legislation. The Board and the Manager
continually monitor regulatory, legislative and tax developments to ensure early engagement in any areas of potential change.
KEY PROFESSIONALS Loss of key professionals at the Manager could impair the Company’s ability to deliver its investment strategy and meet its external obligations if replacements are not found in a timely manner. If the Manager’s team is not able to deliver its objectives, investment opportunities could be missed or misevaluated, while existing investment performance may suffer. The Manager regularly updates the Board on team developments and succession planning. The Manager places significant focus on: Stable The Board reviewed the Company’s exposure to people risk and concluded that the Manager continues to operate sustainable succession, competitive remuneration and retention plans. The Board believes that the risk in respect of people remains stable.
Developing key individuals to ensure that there is a pipeline of potential succession candidates internally. External
appointments are considered if that best satisfies the business needs. A team-based approach to investment decision-making, i.e.
no one investment professional has sole responsibility for an investment or fund manager relationship. Sharing insights and
knowledge widely across the investment team, including discussing all potential new investments and the overall performance of
the Portfolio. Designing and implementing a compensation policy that helps to minimise turnover of key people.
THE MANAGER AND THIRD-PARTY PROVIDERS (INCLUDING BUSINESS PROCESSES, BUSINESS CONTINUITY AND CYBER) The Company is dependent on third parties for the provision of services and systems, especially those of the Manager, the Administrator and the Depositary. Failure by a third-party provider to deliver services in accordance with its contractual obligations could disrupt or compromise the functioning of the Company. A material loss of service could result in, among other things, an inability to perform business critical functions, financial loss, legal liability, regulatory censure and reputational damage. The failure of the Manager and Administrator to deliver an appropriate cyber security platform for critical technology systems could result in unauthorised access by malicious third parties, breaching the confidentiality, integrity and availability of Company data, negatively impacting the Company’s reputation. The performance of the Manager, the Administrator, the Depositary and other third-party providers is subject to regular review Stable The Board carries out a formal annual assessment (supported by the Manager’s internal audit function) of the Manager’s internal controls and risk management systems. The Board also received regular reporting from the Manager and other third parties. Following this review and other considerations, the Board concluded that there was no material change in the Manager and other third-party suppliers risk.
and reported to the Board. The Manager, the Administrator and the Depositary produce internal control reports to provide
assurance regarding the effective operation of internal controls. These reports are provided to the Audit Committee for review.
The Committee would seek further representations from service providers if not satisfied with the effectiveness of their control
environment. The Audit Committee formally assesses the internal controls of the Manager, the Administrator and Depositary on an
annual basis to ensure adequate controls are in place. The assessment in respect of the current year is discussed in the Report
of the Audit Committee. The Management Agreement and agreements with other third-party service providers are subject to notice
periods that are designed to provide the Board with adequate time to put in place alternative arrangements.
FINANCIAL RISKS
FINANCING The Company has outstanding commitments to private equity funds in excess of total liquidity that may be drawn down at any time. The ability to fund this difference is dependent on receiving cash proceeds from investments (the timing of which are unpredictable) and the availability of financing facilities. If the Company encountered difficulties in meeting its outstanding commitments, there would be significant reputational damage as well as risk of damages being claimed from managers and other counterparties. The Manager monitors the Company’s liquidity, overcommitment ratio and covenants on a frequent basis, and undertakes cash flow Stable The Board reviewed the Company’s exposure to financing risk, noting the Net Debt position, the increase in available facility and the short-term realisation forecast and concluded that this risk was stable.
monitoring, and provides regular updates on these activities to the Board.
Audited Financial Statements for the year ended 31 January 2025
INCOME STATEMENT
Year to 31 January 2025 Year to 31 January 2024
Notes Revenue return £’000 Capital return £’000 Total £’000 Revenue return £’000 Capital return £’000 Total £’000
Investment returns
Income, gains and losses on investments 2,10 1,060 134,156 135,216 2,365 39,369 41,734
Deposit interest 2 48 — 48 405 — 405
Other income 2 5 — 5 104 — 104
Foreign exchange gains and losses — (729) (729) — 1,193 1,193
1,113 133,427 134,540 2,874 40,562 43,436
Expenses
Investment management charges 3 (1,618) (14,558) (16,175) (1,615) (14,533) (16,148)
Other expenses including finance costs 4 (2,439) (8,417) (10,855) (2,520) (7,402) (9,922)
(4,057) (22,974) (27,031) (4,135) (21,935) (26,070)
Profit/(loss) before tax (2,943) 110,453 107,510 (1,261) 18,627 17,366
Taxation 6 — — — —
Profit/(loss) for the period (2,943) 110,453 107,510 (1,261) 18,627 17,366
Attributable to:
Equity shareholders (2,943) 110,453 107,510 (1,261) 18,627 17,366
Basic and diluted earnings per share 7 163.95p 25.63p
The columns headed ‘Total’ represent the income statement for the relevant
financial years and the columns headed ‘Revenue return’ and ‘Capital
return’ are supplementary information in line with guidance published by the
AIC. There is no Other Comprehensive Income.
All profits are from continuing operations.
The notes on pages 34 to 59 form an integral part of the financial statements.
BALANCE SHEET
Notes 31 January 2025 £’000 31 January 2024 £’000
Non-current assets
Investments held at fair value 9,10,17 1,469,549 1,296,382
Current assets
Cash and cash equivalents 11 3,927 9,722
Prepayments and receivables 12 2,018 2,258
5,945 11,980
Current liabilities
Borrowings (131,931) (20,000)
Payables 13 (11,171) (5,139)
Net current assets / (liabilities) (137,157) (13,159)
Total assets less current liabilities 1,332,392 1,283,223
Capital and reserves
Share capital 14 7,292 7,292
Capital redemption reserve 2,112 2,112
Share premium 12,936 12,936
Capital reserve 1,315,727 1,279,751
Revenue reserve (5,675) (2,733)
Total equity 1,332,392 1,283,223
Net Asset Value per Share (basic and diluted) 15 2072.9p 1909.4p
The notes on pages 34 to 59 form an integral part of the financial statements.
The financial statements on pages 30 to 59 were approved by the Board of
Directors on 7 May 2025 and signed on its behalf by:
Jane Tufnell Alastair Bruce
Director Director
CASH FLOW STATEMENT
Notes Year to 31 January 2025 £’000 Year to 31st January 2024 £’000
Operating activities
Sale of portfolio investments 19,966 40,611
Purchase of portfolio investments (34,144) (25,162)
Cash flow to subsidiaries' investments (152,174) (116,084)
Cash flow from subsidiaries' investments 125,769 195,300
Interest income received from portfolio investments 494 1,695
Dividend income received from portfolio investments 547 779
Other income received 53 509
Investment management charges paid (16,021) (15,647)
Other expenses paid (1,881) (2,596)
Net cash inflow/(outflow) from operating activities (57,391) 79,405
Financing activities
Bank facility fee paid (2,011) (3,970)
Interest paid (545) (5,571)
Credit Facility utilised 139,762 128,109
Credit Facility repaid (27,831) (174,954)
Purchase of shares into treasury (35,851) (13,068)
Equity dividends paid 8 (22,308) (21,694)
Net cash (outflow)/inflow from financing activities 51,215 (91,148)
Net decrease in cash and cash equivalents (6,176) (11,743)
Cash and cash equivalents at beginning of year 11 9,722 20,694
Net decrease in cash and cash equivalents (6,176) (11,743)
Effect of changes in foreign exchange rates 381 771
Cash and cash equivalents at end of period 11 3,927 9,722
1. Includes settlement of unbilled management fees relating to the prior year
(see note 13).
The notes on pages 34 to 59 form an integral part of the financial statements.
STATEMENT OF CHANGES IN EQUITY
Share capital £’000 Capital redemption reserve £’000 Share premium £’000 Realised capital reserve (1) £’000 Unrealised capital reserve £’000 Revenue reserve (1) £’000 Total shareholders’ equity £’000
Opening balance at 1 February 2024 7,292 2,112 12,936 473,015 790,602 (2,733) 1,283,223
Profit for the period and total comprehensive income — — — (6,033) 116,485 (2,942) 107,510
Capital distribution by subsidiary (2) — — — — — — —
Dividends paid — — — (22,308) — — (22,308)
Purchase of shares into treasury — — — (36,033) — — (36,033)
Closing balance at 31 January 2025 7,292 2,112 12,936 408,641 907,087 (5,675) 1,332,392
Share capital £’000 Capital redemption reserve £’000 Share premium £’000 Realised capital reserve (1) £’000 Unrealised capital reserve £’000 Revenue reserve (1) £’000 Total shareholders’ equity £’000
Opening balance at 1 February 2023 7,292 2,112 12,936 468,054 811,698 (1,473) 1,300,619
Profit for the period and total comprehensive income — — — 31,032 (12,405) (1,261) 17,366
Capital distribution by subsidiary (2) — — — 8,691 (8,691) — —
Dividends paid — — — (21,694) — — (21,694)
Purchase of shares into treasury — — — (13,068) — — (13,068)
Closing balance at 31 January 24 7,292 2,112 12,936 473,015 790,602 (2,734) 1,283,223
1. Distributable reserves.
2. During the prior reporting period ICG Enterprise Trust Limited Partnership
made a distribution of realised profits totalling £8.6m to the Company.
The notes on pages 34 to 59 form an integral part of the financial statements.
NOTES TO THE FINANCIAL STATEMENTS
1 ACCOUNTING POLICIES
General information
These financial statements relate to ICG Enterprise Trust Plc (‘the
Company’). ICG Enterprise Trust Plc is registered in England and Wales and
is incorporated in the United Kingdom. The Company is domiciled in the United
Kingdom and its registered office is Procession House, 55 Ludgate Hill, London
EC4M 7JW. The Company’s objective is to provide long-term growth by
investing in private companies managed by leading private equity managers.
(a) Basis of preparation
The financial information for the year ended 31 January 2025 has been prepared
in accordance with UK-adopted International Accounting Standards
(‘UK-IAS’) and the Statement of Recommended Practice (‘SORP’) for
investment trusts issued by the Association of Investment Companies in July
2022.
UK-IAS comprises standards and interpretations approved by the International
Accounting Standards Board (‘IASB’) and the IFRS Interpretations
Committee.
These financial statements have been prepared on a going concern basis and on
the historical cost basis of accounting, modified for the revaluation of
certain assets at fair value. The directors have concluded that the
preparation of the financial statements on a going concern basis continues to
be appropriate.
Going concern
In assessing the appropriateness of continuing to adopt the going concern
basis of accounting, the Board has assessed the financial position and
prospects of the Company. The Company’s business activities, together with
factors likely to affect its future development, performance, position and
cash flows, are set out in the Chair’s statement on page 5, and the
Manager’s review on page 7.
As part of this review, the Board assessed the potential impact of principal
risks on the Company’s business activities, the Company’s cash position,
the availability of the Company’s credit facility and compliance with its
covenants, and the Company’s cash flow projections.
Based on this assessment, the Board expects that the Company will be able to
continue in operation and meet its liabilities as they fall due until, at
least, 31 May 2026, a period of more than 12 months from the signing of the
financial statements. Therefore it is appropriate to continue to adopt the
going concern basis of preparation of the Company’s financial statements.
Climate change
In preparing the financial statements, the directors have considered the
impact of climate change, particularly in the context of the climate change
risks identified in the Principal risks and uncertainties section of this
Report, and the impact of climate change risk on the valuation of investments.
These considerations did not have a material impact on the financial reporting
judgements and estimates in the current year, nor were they expected to have a
significant impact on the Company’s going concern or viability.
Accounting policies
The principal accounting policies adopted are set out below. These policies
have been applied consistently throughout the current and prior year. In order
to reflect the activities of an investment trust company, supplementary
information which analyses the income statement between items of revenue and
capital nature has been presented alongside the income statement. In analysing
total income between capital and revenue returns, the directors have followed
the guidance contained in the SORP as follows:
Capital gains and losses on investments sold and on investments held arising
on the revaluation or disposal of investments classified as held at fair value
through profit or loss should be shown in the capital column of the income
statement.
Returns on any share or debt security for a fixed amount (whether in respect
of dividends, interest or otherwise) should be shown in the revenue column of
the income statement.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
The Board should determine whether the indirect costs of generating capital
gains should also be shown in the capital column of the income statement. If
the Board decides that this should be so, the management fee should be
allocated between revenue and capital in accordance with the Board’s
expected long-term split of returns, and other expenses should be charged to
capital only to the extent that a clear connection with the maintenance or
enhancement of the value of investments can be demonstrated.
The accounting policy regarding the allocation of expenses is set out in note
1(i).
In accordance with IFRS 10 (amended), the Company is deemed to be an
investment entity on the basis that:
(a) it obtains funds from one or more investors for the purpose of providing
investors with investment management services;
(b) it commits to its investors that its business purpose is to invest funds
for both returns from capital appreciation and investment income; and
(c) it measures and evaluates the performance of substantially all of its
investments on a fair value basis.
As a result, the Company’s controlled structured entities
(‘subsidiaries’) are deemed to be investments and are classified as held
at fair value through profit and loss.
(b) Financial assets
The Company classifies its financial assets in the following categories: at
fair value through profit or loss; and at amortised cost. The classification
depends on the purpose for which the financial assets were acquired. The
classification of financial assets is determined at initial recognition.
Financial assets at fair value through profit or loss
The Company classifies its quoted and unquoted investments as financial assets
at fair value through profit or loss. These assets are measured at subsequent
reporting dates at fair value and further details of the accounting policy are
disclosed in note 1(c).
Financial assets at amortised cost
Financial assets at amortised cost are non-derivative financial assets which
pass the contractual cash flow test and are held to receive contractual cash
flows. These are classified as current assets and measured at amortised cost
using the effective interest rate method. The Company’s financial assets at
amortised cost comprise cash and cash equivalents and trade and other
receivables in the balance sheet.
(c) Investments
Investments comprise fund investments and portfolio company investments held
by the Company directly, together with the fair value of the Company’s
interest in controlled structured entities (see note 9) which themselves
invest in fund investments and portfolio company investments.
All investments are classified upon initial recognition as held at fair value
through profit or loss (described in these financial statements as investments
held at fair value) and are measured at subsequent reporting dates at fair
value. All investments are fair valued in line with IFRS 13 ‘Fair Value
Measurement’, using industry standard valuation guidelines such as the
International Private Equity and Venture Capital (‘IPEV’) valuation
guidelines. Changes in the value of all investments held at fair value, which
include returns on those investments such as dividends and interest, are
recognised in the income statement and are allocated to the revenue column or
the capital column in accordance with the SORP (see note 1(a)). More detail on
certain categories of investment is set out below. Given that the subsidiaries
and associates are held at fair value and are exposed to materially similar
risks as the Company, we do not expect the risks to materially differ from
those disclosed in note 17.
Unquoted Investments
Fund investments and Co-investments (collectively ‘unquoted investments’)
are fair valued using the net asset value of those unquoted investments as
determined by the third-party investment manager of those funds. The
third-party investment manager performs periodic valuations of the underlying
investments in their funds, typically using earnings multiple or discounted
cash flow methodologies to determine enterprise value in line with IPEV
Guidelines. In the absence of contrary information, these net asset valuations
received from the third-party investment managers are deemed to be
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
appropriate by the Manager, for the purposes of the Manager’s determination
of the fair values of the unquoted investments. A robust assessment is
performed by the Manager’s experienced Investment Committee to determine the
capability and track record of the investment manager. All investment managers
are scrutinised by the Investment Committee and an approval process is
recorded before any new investment manager is approved and an investment made.
This level of scrutiny provides reasonable comfort that the investment
manager’s valuation will be consistent with the requirement to use fair
value.
Adjustments may be made to the net asset values provided or an alternative
valuation method may be adopted if deemed to be more appropriate. The most
common reason for adjustments to the value provided by an underlying manager
is to take account of events occurring between the date of the manager’s
valuation and the reporting date, for example, subsequent cash flows or
notification of an agreed sale.
Subsidiary undertakings
The investments in the controlled structured entities (‘subsidiaries’) are
recognised at fair value through profit and loss.
The valuation of the subsidiaries takes into account an accrual for the
estimated value of interests in the Co-investment Incentive Scheme. Under
these arrangements, ICG (the ‘Manager’) and certain of its executives and,
in respect of certain historic investments, the executives and connected
parties of Graphite Capital Management LLP (the ‘Former Manager’)
(together ‘the Co-investors’), are required to co-invest alongside the
Company, for which they are entitled to a share of investment profits if
certain performance hurdles are met. At 31 January 2024, the accrual was
estimated as the theoretical value of the interests if the Portfolio had been
sold at the carrying value at that date.
Associates
The Company holds an interest (including indirectly through its subsidiaries)
of more than 20% in a small number of investments that may normally be
classified as subsidiaries or associates. These investments are not considered
subsidiaries or associates as the Company does not exert control or
significant influence over the activities of these companies/structured
entities as they are managed by other third parties.
(d) Prepayments and receivables
Receivables include unamortised fees which were incurred directly in relation
to the agreement of a financing facility. These fees will be amortised over
the life of the facility on a straight-line basis.
(e) Payables
Other payables are non-interest bearing and are stated at their amortised
cost, which is not materially different from fair value.
(f) Cash and cash equivalents
Cash and cash equivalents comprise cash and short-term bank deposits with an
original maturity of three months or less.
(g) Dividend distributions
Dividend distributions to shareholders are recognised in the period in which
they are paid.
(h) Income
When it is probable that economic benefits will flow to the Company and the
amount can be measured reliably, interest is recognised on a time
apportionment basis.
Dividends receivable on quoted equity shares are brought into account on the
ex-dividend date. Dividends receivable on equity shares where no ex-dividend
date is applicable are brought into account when the Company’s right to
receive payment is established.
UK dividend income is recorded at the amount receivable. Overseas dividend
income is shown net of withholding tax. Income distributions from funds are
recognised when the right to distributions is established.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
(i) Expenses
All expenses are accounted for on an accruals basis. Expenses are allocated to
the revenue column in the income statement, consistent with the SORP, with the
following exceptions:
* Expenses which are incidental to the acquisition or disposal of investments
(transaction costs) are allocated to the capital column
* The Board expects the majority of long-term returns from the Portfolio to be
generated from capital gains. Expenses are allocated 90% to the capital column
and 10% to the revenue column, reflecting the Company’s current and future
return profile. Other expenses are allocated to the capital column where a
clear connection with the maintenance or enhancement of the value of
investments can be demonstrated.
* All expenses allocated to the capital column are treated as realised capital
losses (see note 1(l)).
(j) Taxation
Investment trusts which have approval as such under Section 1158 of the
Corporation Tax Act 2010 are not liable for taxation on capital gains.
Tax recognised in the income statement represents the sum of current tax and
deferred tax charged or credited in the year. The tax effect of different
items of expenditure is allocated between capital and revenue on the same
basis as the particular item to which it relates.
Deferred tax is the tax expected to be payable or recoverable on the
difference between the carrying amounts of assets and liabilities in the
financial statements and the corresponding tax bases used in the computation
of taxable profit, and is accounted for using the balance sheet liability
method.
Deferred tax liabilities are recognised for all taxable temporary differences
and deferred tax assets are recognised to the extent that it is probable that
taxable profits will be available against which deductible temporary
differences can be utilised. Deferred tax assets are not recognised in respect
of tax losses carried forward to future periods.
Deferred tax is calculated at the tax rates that are expected to apply in the
period when the liability is settled or the assets are realised. Deferred tax
is charged or credited in the income statement, except when it relates to
items charged or credited directly to equity, in which case the deferred tax
is also dealt with in equity.
(k) Foreign currency translation
The functional and presentation currency of the Company is sterling,
reflecting the primary economic environment in which the Company operates.
Transactions in currencies other than sterling are recorded at the rates of
exchange prevailing on the dates of the transactions. At each balance sheet
date, financial assets and liabilities denominated in foreign currencies are
translated at the rates prevailing on the balance sheet date.
Gains and losses arising on the translation of investments held at fair value
are included within gains and losses on investments held at fair value in the
income statement. Gains and losses arising on the translation of other
financial assets and liabilities are included within foreign exchange gains
and losses in the income statement.
(l) Revenue and capital reserves
The revenue return component of total income is taken to the revenue reserve
within the statement of changes in equity. The capital return component of
total income is taken to the capital reserve within the statement of changes
in equity.
Gains and losses on the realisation of investments including realised exchange
gains and losses and expenses of a capital nature are taken to the realised
capital reserve (see note 1(i)). Changes in the valuations of investments
which are held at the year end and unrealised exchange differences are
accounted for in the unrealised capital reserve.
Net gains on the realisation of investments in the controlled structured
entities (see note 9) are transferred to the Company by way of profit
distributions.
The revenue reserve is distributable by way of dividends to shareholders. The
realised capital reserve is distributable by way of dividends and share
buybacks. The capital redemption reserve is not distributable and represents
the nominal value of shares bought back for cancellation.
(m) Treasury shares
Shares that have been repurchased into treasury remain included in the share
capital balance, unless they are cancelled.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
(n) Critical estimates and assumptions
Estimates and judgements used in preparing the financial information are
continually evaluated and are based on historical experience and other
factors, including expectations of future events that are believed to be
reasonable. The resulting estimates will, by definition, seldom equal the
related actual results.
In preparing the financial statements, the directors have considered the
impact of climate change on the key estimates within the
financial statements.
The only estimates and assumptions that have a significant risk of causing a
material adjustment to the carrying values of assets and liabilities in the
next financial year relate to the valuation of unquoted investments. Unquoted
investments are primarily the Company’s investments in unlisted funds,
managed by third-party investment fund managers and ICG. As such there is
significant estimation in the valuation of the unlisted fund at a point in
time. Note 1(c) sets out the accounting policy for unquoted investments. The
carrying amount of unquoted investments at the year end is disclosed within
note 10.
(o) Segmental reporting
Operating segments are reported in a manner consistent with the internal
reporting provided to the chief operating decision maker. The chief operating
decision maker who is responsible for allocating resources and assessing
performance of the segments has been identified as the Board. It is considered
that the Company’s operations comprise a single operating segment.
2 INVESTMENT RETURNS
Year ended Year ended
31 January 2025 31 January 2024
£’000 £’000
Income from investments
Overseas interest and dividends 1,060 2,365
1,060 2,365
Deposit interest on cash 48 405
Other 5 104
53 509
Total income 1,113 2,874
Analysis of income from investments
Unquoted 1,060 2,365
1,060 2,365
3 INVESTMENT MANAGEMENT CHARGES
Management fees paid to ICG for managing ICG Enterprise Trust amounted to
1.25% (2024: 1.25%) of the average net assets in the year. The reduction in
the fee is due to the application of the cap.
From 1 February 2023 the management fee is subject to a cap of 1.25% of net
asset value.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
3 INVESTMENT MANAGEMENT CHARGES CONTINUED
The amounts charged during the year are set out below:
Year ended 31 January 2025 Year ended 31 January 2024
Revenue Capital Total Revenue Capital Total
£’000 £’000 £’000 £’000 £’000 £’000
Investment management charge 1,617 14,558 16,175 1,615 14,533 16,148
The Company and its subsidiaries also incur management fees in respect of its
investment in funds managed by members of ICG on an arms-length basis.
Year ended Year ended
31 January 2025 31 January 2024
£’000 £’000
ICG Europe VIII 434 467
ICG Strategic Equity V 353 131
ICG Strategic Equity IV 340 593
ICG LP Secondaries Fund I LP 325 55
ICG Europe VII 238 257
ICG Strategic Equity III 238 183
ICG Europe Mid-Market II 95 87
ICG Augusta Partners Co-Investor II 89 91
ICG Europe Mid-Market 87 120
ICG North American Private Debt II 68 74
ICG Strategic Secondaries II 36 74
ICG Europe VI 23 41
ICG Asia Pacific III 15 30
ICG Recovery Fund 2008B 3 31
ICG Europe V 2 1
2,346 2,235
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
4 OTHER EXPENSES
The Company did not employ any staff in the year to 31 January 2025 (2024:
none).
Year ended Year ended
31 January 2025 31 January 2024
£’000 £’000 £’000 £’000
Directors’ fees (see note 5) 340 316
Fees payable to the Company’s auditor for the audit of the Company’s annual accounts 170 239
Fees payable to the Company’s auditor and its associates for other services:
- Audit of the accounts of the subsidiaries 108 139
- Audit-related assurance services 71 53
Total auditors’ remuneration 349 431
Administrative expenses 811 1,021
1,500 1,768
Bank facility costs allocated to revenue 277 258
Interest costs allocated to revenue 661 493
Expenses allocated to revenue 2,438 2,519
Bank facility costs allocated to capital 8,417 7,403
Total other expenses 10,855 9,922
1. The auditors of the Company have additionally provided £16k (2024: £14k)
of non-audit related services permitted under the Financial Reporting
Council’s (‘FRC’) Revised Ethical Standards. The service related to
agreed upon procedures over the Company’s carried interest scheme. These
expenses have been charged to the Manager of the Company.
Included within Total other expenses above are £9.4m (2024: £8.2m) of costs
related to financing and £(0.2)m (credit) (2024: £0.1m) of other expenses
which are non-recurring and are excluded from the Ongoing Charges as detailed
in the glossary on page 58.
Professional fees of £0.2m (2024: £0.2m) incidental to the acquisition or
disposal of investments are included within gains/(losses) on investments held
at fair value.
5 DIRECTORS’ REMUNERATION AND INTERESTS
No income was received or receivable by the directors from any other
subsidiary of the Company.
6 TAXATION
In both the current and prior years the tax charge was lower than the standard
rate of corporation tax of 19%, principally due to the Company’s status as
an investment trust, which means that capital gains are not subject to
corporation tax. The effect of this and other items affecting the tax charge
are shown in note 6(b) below.
The UK's main rate of corporation tax increased from 19% to 25% with effect
from 1 April 2023. A blended rate of 24% was applied for the year ended 31
January 2024, calculated by the number of days within the accounting period
spanning the rate change. A corporation tax rate of 25% was applied for the
year ended 31 January 2025.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Year ended Year ended
31 January 2025 31 January 2024
£’000 £’000
a) Analysis of charge in the year
Tax credit on items allocated to revenue — —
Tax charge on items relating to prior years — —
Corporation tax — —
b) Factors affecting tax charge for the year
Profit on ordinary activities before tax 107,510 17,367
Profit before tax multiplied by rate of corporation tax in the UK of 25% (2024: 24%) 26,790 4,168
Effect of:
– net investment returns not subject to corporation tax (33,357) (9,735)
– dividends not subject to corporation tax (52) (187)
– expenses not deductible for tax purposes 1,353 —
– current year management expenses not utilised/(utilised) 489 5,754
– other deductions 4,777 —
Total tax charge — —
The Company has £70.0m excess management expenses carried forward (2024:
£53.5m). No deferred tax assets or liabilities (2024: nil) have been
recognised in respect of the carried forward management expenses due to the
uncertainty that future taxable profit will be generated that these losses can
be offset against. For all investments the tax base is equal to the carrying
amount. There was no deferred tax expense relating to the origination and
reversal of timing differences in the year (2024: nil).
7 EARNINGS PER SHARE
Year ended Year ended
31 January 2025 31 January 2024
Revenue return per ordinary share (4.49p) (1.86p)
Capital return per ordinary share 168.38p 27.49p
Earnings per ordinary share (basic and diluted) 163.95p 25.63p
Revenue return per ordinary share is calculated by dividing the revenue return
attributable to equity shareholders of £(2.9)m (2024: £(1.3)m) by the
weighted average number of ordinary shares outstanding during the year.
Capital return per ordinary share is calculated by dividing the capital return
attributable to equity shareholders of £102.4m (2024: £18.6m) by the
weighted average number of ordinary shares outstanding during the year.
Basic and diluted earnings per ordinary share are calculated by dividing the
earnings attributable to equity shareholders of £99.5m (2024: £17.4m) by the
weighted average number of ordinary shares outstanding during the year.
The weighted average number of ordinary shares outstanding (excluding those
held in treasury) during the year was 65,569,285 (2024: 67,761,359). There
were no potentially dilutive shares, such as options or warrants, in either
year.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
8 DIVIDENDS
Year ended Year ended
31 January 2025 31 January 2024
£’000 £’000
Third quarterly dividend in respect of year ended 31 January 2024: 8p per share (2023: 6.0p) 5,345 4,781
Final dividend in respect of year ended 31 January 2024: 9p per share (2023: 9.0p) 5,894 6,105
First quarterly dividend in respect of year ended 31 January 2025: 8.5p per share (2024: 8.0p) 5,557 5,415
Second quarterly dividend in respect of year ended 31 January 2025: 8.5p per share (2024: 8.0p) 5,512 5,393
Total 22,308 21,694
The Company paid a third quarterly dividend of 8.5p per share in February
2025. The Board has proposed a final dividend of 10.5p per share (estimated
cost £6.7m) in respect of the year ended 31 January 2025 which, if approved
by shareholders, will be paid on 18 July 2025 to shareholders on the Register
of Members at the close of business on 04 July 2025.
9 SUBSIDIARY UNDERTAKINGS AND UNCONSOLIDATED STRUCTURED ENTITIES
Subsidiary undertakings (controlled structured entities)
Subsidiaries of the Company as at 31 January 2025 comprise the following
controlled structured entities, which are registered in England and Wales.
Subsidiaries of the Company’s direct subsidiaries are reported as indirect
subsidiaries.
Direct subsidiaries Ownership interest 2025 Ownership interest 2024
ICG Enterprise Trust Limited Partnership 97.5% 97.5%
ICG Enterprise Trust (2) Limited Partnership 97.5% 97.5%
ICG Enterprise Trust Co-investment Limited Partnership 99.0% 99.0%
Indirect subsidiaries Ownership interest 2025 Ownership interest 2024
ICG Enterprise Holdings LP 99.5% 99.5%
ICG Morse Partnership LP 99.5% 99.5%
ICG Lewis Partnership LP 99.5% 99.5%
In accordance with IFRS 10 (amended), the subsidiaries are not consolidated
and are instead included in unquoted investments at fair value.
The value of the subsidiaries is shown net of an accrual for the interests of
the Co-investors (ICG and certain of its executives and in respect of certain
historical investments, the executives and connected parties of Graphite
Capital, the Former Manager) in the Co-investment Incentive Scheme. As at 31
January 2025 a total of £53.9m (2024: £54.4m) was accrued in respect of
these interests. During the year the Co-investors invested £1.0m (2024:
£0.7m) into ICG Enterprise Trust Co-investment Limited Partnership. Payments
received by the Co-investors amounted to £10.8m or 7.1% of £150.8m of Total
Proceeds received in the year (2024: £5.4m or 2.3% of £238.6m proceeds
received).
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Unconsolidated structured entities
The Company’s principal activity is investing in private equity funds and
directly into private companies. Such investments may be made and held via a
subsidiary. The majority of these investments are unconsolidated structured
entities as defined in IFRS 12.
The Company holds interests in closed-ended limited partnerships which invest
in underlying companies for the purposes of capital appreciation. The Company
and the other limited partners make commitments to finance the investment
programme of the relevant manager, who will typically draw down the amount
committed by the limited partners over a period of four to six years (see note
16).
The table below disaggregates the Company’s interests in unconsolidated
structured entities. The table presents for each category the related balances
and the maximum exposure to loss.
Unquoted investments £'000 Co-investment Incentive Scheme accrual £'000 Maximum loss exposure £'000
As at 31 January 2025 1,523,459 (53,910) 1,469,549
As at 31 January 2024 1,350,821 (54,439) 1,296,382
Further details of the Company’s investment Portfolio are included in the
Portfolio dashboard on page 16.
10 INVESTMENTS
The tables below analyse the movement in the carrying value of the Company’s
investment assets in the year. In accordance with accounting standards,
subsidiary undertakings of the Company are reported at fair value rather than
on a ‘look-through’ basis.
An investee fund is considered to generate realised gains or losses if it is
more than 85% drawn and has returned at least the amount invested by the
Company. All gains and losses arising from the underlying investments of such
funds are presented as realised. All gains and losses in respect of fund
investments that have not satisfied the above criteria are presented as
unrealised.
Direct Investments are considered to generate realised gains or losses when
they are sold.
Investments are held by both the Company and through its subsidiaries.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Quoted Unquoted Subsidiary undertakings Total
£’000 £’000 £’000 £’000
Cost at 1 February 2024 — 179,528 300,114 479,642
Unrealised appreciation at 1 February 2024 — 80,768 735,972 816,740
Valuation at 1 February 2024 — 260,296 1,036,086 1,296,382
Movements in the year:
Purchases — 34,144 151,292 185,436
Sales
– capital proceeds (20,214) (125,769) (145,983)
– realised gains/(losses) based on carrying value at previous balance sheet date 1,530 1,530
Movement in unrealised appreciation 29,473 102,711 132,184
Valuation at 31 January 2025 — 305,229 1,164,320 1,469,549
Cost at 31 January 2025 — 193,458 325,637 519,095
Unrealised appreciation/ (depreciation) at 31 January 2025 — 111,771 838,683 950,454
Valuation at 31 January 2025 — 305,229 1,164,320 1,469,549
Quoted Unquoted Subsidiary undertakings Total
£’000 £’000 £’000 £’000
Cost at 1 February 2023 — 195,104 378,426 573,530
Unrealised appreciation at 1 February 2023 — 74,074 701,471 775,545
Valuation at 1 February 2023 — 269,178 1,079,897 1,349,075
Movements in the year:
Purchases — 25,181 116,988 142,169
Sales
– capital proceeds (40,757) (195,300) (236,057)
– realised gains/(losses) based on carrying value at previous balance sheet date (1,044) (1,044)
Movement in unrealised appreciation 7,739 34,500 42,239
Valuation at 31 January 2023 — 260,296 1,036,086 1,296,382
Cost at 31 January 2024 — 179,528 300,114 479,642
Unrealised appreciation/ (depreciation) at 31 January 2024 — 80,768 735,972 816,740
Valuation at 31 January 2024 — 260,296 1,036,086 1,296,382
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
31 January 2025 31 January 2024
£’000 £’000
Realised gains/loss based on cost 1,530 (1,044)
Amounts recognised as unrealised in previous years — —
Realised gains based on carrying values at previous balance sheet date 1,530 (1,044)
Increase in unrealised appreciation 132,184 42,239
Gains on investments 133,714 41,195
‘Realised gains based on cost’ represents the total increase in value,
compared to cost, of those funds which meet the criteria set out in page 42.
These gains are adjusted for amounts previously reported as unrealised (and
included within the fair value at the previous balance sheet date) to
determine the ‘Realised gains based on carrying values at previous balance
sheet date’.
Gains on investments includes the ‘Realised gains based on carrying values
at previous balance sheet date’ together with the net fair value movement on
the balance of the investee funds.
Related undertakings
At 31 January 2025, the Company held direct and indirect interests in six
limited partnership subsidiaries. These interests, net of the incentive
accrual as described in note 9, were:
Investment 31 January 2025 % 31 January 2024 %
ICG Enterprise Trust Limited Partnership 99.9% 99.9%
ICG Enterprise Trust (2) Limited Partnership 66.5% 66.5%
ICG Enterprise Trust Co-investment Limited Partnership 66.0% 66.0%
ICG Enterprise Holdings LP 99.5% 99.5%
ICG Morse Partnership LP 99.5% 99.5%
ICG Lewis Partnership LP 99.5% 99.5%
The registered address and principal place of business of the subsidiary
partnerships is Procession House, 55 Ludgate Hill, London EC4M 7JW.
In addition the Company held an interest (including indirectly through its
subsidiaries) of more than 20% in the following entities. These investments
are not considered subsidiaries or associates as the Company does not exert
control or have significant influence over the activities of these
companies/partnerships.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
As at 31 January 2025
Investment Instrument % interest (1)
Graphite Capital Partners VII Top Up Plus Limited partnership interests 20.0%
Graphite Capital Partners VIII Top Up Limited partnership interests 41.1%
ICG Velocity (3) Limited partnership interests 32.5%
As at 31 January 2024
Investment Instrument % interest (1)
Graphite Capital Partners VII Top Up Plus (2) Limited partnership interests 20.0%
Graphite Capital Partners VIII Top Up (2) Limited partnership interests 41.1%
ICG Velocity (3) Limited partnership interests 32.5%
1. The percentage shown for limited partnership interests represents the
proportion of total commitments to the relevant fund. The percentage shown for
shares represents the proportion of total shares in issue.
2. Address of principal place of business is 7 Air Street, Soho, London W1B
5AD.
3. Address of principal place of business is Procession House, 55 Ludgate
Hill, London, EC4M 7JW.
11 CASH AND CASH EQUIVALENTS
31 January 2025 31 January 2024
£’000 £’000
Cash at bank and in hand 3,927 9,722
12 PREPAYMENTS AND RECEIVABLES
31 January 2025 31 January 2024
£’000 £’000
Prepayments and accrued income 2,018 2,258
As at 31 January 2025, prepayments and accrued income included £2.0m (2024:
£2.3m) of unamortised costs in relation to the bank facility. Of this amount
£0.8m (2024: £0.5m) is expected to be amortised in less than one year.
13 PAYABLES – CURRENT
31 January 2025 31 January 2024
£’000 £’000
Accruals, including facility interest 11,171 5,139
Bank facility drawn 131,931 20,000
Payables 143,102 25,139
Bank facility details are shown in the liquidity section of note 17 on page
52.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
14 SHARE CAPITAL
Authorised Issued and fully paid
Nominal Nominal
Equity share capital Number £’000 Number £’000
Balance at 31 January 2025 120,000,000 12,000 72,913,000 7,292
Balance at 31 January 2024 120,000,000 12,000 72,913,000 7,292
All ordinary shares have a nominal value of 10.0p. At 31 January 2025 and 31
January 2024, 72,913,000 shares had been allocated, called up and fully paid.
During the year 2,932,675 shares were bought back in the market and held in
treasury (2024: 1,130,708 shares). At 31 January 2025, the Company held
8,640,808 shares in treasury (2024: 5,708,133) and had 64,272,192 (2024:
67,204,867) shares outstanding, all of which have equal voting rights.
31 January 2025 31 January 2024
Shares held in treasury 8,640,808 5,708,133
Shares not held in treasury 64,272,192 67,204,867
Total 72,913,000 72,913,000
15 NET ASSET VALUE PER SHARE
The net asset value per share is calculated on equity attributable to equity
holders of £1,332.4m (2024: £1,283.2m) and on 67,272,192 (2024: 67,204,867)
ordinary shares in issue at the year end. There were no potentially dilutive
shares, such as options or warrants, at either year end. Calculated on both
the basic and diluted basis the net asset value per share was 2,072.9p (2024:
1,909.4p).
16 CAPITAL COMMITMENTS AND CONTINGENCIES
The Company and its subsidiaries had uncalled commitments in relation to the
following Portfolio investments:
31 January 2025 £’000 31 January 2024 £’000
ICG LP Secondaries Fund I LP 41,146 34,811
ICG Strategic Equity V (2) 36,868 19,704
ICG Europe Mid-Market Fund II (1) 19,245 21,316
ICG Augusta Partners Co-Investor (2) 17,775 17,365
ICG Strategic Secondaries Fund II (2) 16,938 16,547
ICG Europe VIII (1) 14,339 25,901
ICG Ludgate Hill (Feeder B) SCSp (1) 13,591 13,860
ICG Strategic Equity Fund III (2) 11,201 10,942
ICG MXV Co-Investment 8,361 —
ICG Strategic Equity IV (2) 7,055 10,385
ICG Europe VII (1) 6,082 6,541
ICG Ludgate Hill (Feeder) IIIA Porsche SCSp (2) 5,691 4,652
ICG Europe Mid-Market Fund (1) 5,524 5,476
ICG Ludgate Hill (Feeder) II Boston SCSp (2) 5,392 5,267
ICG Asia Pacific Fund III (2) 2,523 2,634
ICG Europe VI (1) 4,013 4,311
ICG North American Private Debt Fund II (2) 2,097 1,682
ICG Colombe Co-investment (1) 1,811 2,378
ICG Dallas Co-Investment (2) 1,240 1,280
Commitments of less than £1,000,000 at 31 January 2025 5,746 5,991
Total ICG 226,638 211,043
Graphite Capital Partners IX 2,281 4,525
Graphite Capital Partners VIII (1) 4,124 2,194
Graphite Capital Partners VII (1,2) 456 456
Total Graphite funds 6,861 7,175
1.Includes interest acquired through a secondary fund purchase.
2.Includes the associated Top Up funds.
31 January 2025 £’000 31 January 2024 £’000
Leeds VIII-A 16,135 —
Bowmark VII 15,000 15,000
New Mountain VII 14,299 15,763
PAI Europe VIII 12,356 20,900
Thoma Bravo XVI-A 12,101 —
Investindustrial VIII 12,009 —
Cinven VIII 11,748 12,789
CVC IX A 10,546 12,789
Bain VI 9,939 11,319
CDR XII 8,908 11,822
The Resolute Fund VI 8,577 11,822
Hellman Friedman XI (Parallel) 8,067 7,881
Advent International X-A 8,039 10,849
Bregal Unternehmerkapital IV-A 7,762 8,526
Green Equity Investors Side IX 7,618 15,611
Permira VIII 7,618 9,356
Genstar Capital Partners XI (EU) 7,455 7,850
Apax XI EUR 6,860 8,383
Gridiron V 6,578 9,008
Oak Hill VI (Offshore) 5,034 —
Investindustrial VII 4,895 4,219
Audax Private Equity VII-B 4,546 5,830
Integrum I 4,052 5,715
American Securities IX 4,034 —
Thomas H Lee Equity Fund IX 3,998 6,762
PAI Mid-Market Fund 3,764 4,963
BC XI 3,710 4,900
Bowmark VI 3,357 1,357
Hg Genesis X 3,326 3,469
Ivanti 2,979 2,910
Valeas Capital Partners I A 2,973 —
CVC VII 2,944 —
PAI VII 2,430 2,872
GHO Capital III 2,257 2,617
Bain XIII 2,247 2,739
Audiotonix 2,243 —
Bain Tech Opportunities II 2,239 2,276
Tailwind III 2,203 1,517
Ambassador Theatre Group 2,056 2,049
Thomas H Lee Equity Fund VIII 1,940 2,011
Thoma Bravo XV 1,901 2,648
Hg Saturn III 1,840 2,714
Seventh Cinven Fund 1,812 2,929
GI Partners VI-A 1,789 2,168
Charlesbank X 1,685 3,543
Apax X 1,677 1,442
Hellman Friedman X 1,631 2,194
Bregal Unternehmerkapital III 1,575 2,113
Carlyle Europe Partners V 1,553 2,243
Resolute V 1,363 855
FSN VI 1,303 2,946
Gridiron III 1,289 4,080
AEA VII 1,243 464
Resolute 02 Continuation (SEC 1) 1,145 9,893
CVC European Equity Partners VIII 512 3,402
New Mountain VI 498 2,276
European Camping Group 2 399 1,474
Leeds VII 317 3,581
Commitments of less than £2,000,000 at 31 January 2025 62,785 36,908
Total third party 319,687 333,747
Total commitments 553,186 551,965
The Company and its subsidiaries had no other unfunded commitments to
investment funds. Commitments made by the Company and its subsidiaries are
irrevocable.
As at 31 January 2025, the Company (excluding its subsidiaries) had uncalled
commitments in relation to the above Portfolio of £114.3m (2024: £98.1m).
The Company did not have any contingent liabilities at 31 January 2025 (2024:
None).
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
The Company’s subsidiaries, which are not consolidated, had the balance of
uncalled commitments in relation to the above Portfolio of £438.9m (2024:
£453.9m). The Company is responsible for financing its pro-rata share of
those uncalled commitments (see note 9).
17 FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
The Company is an investment company as defined by Section 833 of the
Companies Act 2006 and conducts its affairs so as to qualify as an investment
trust under the provisions of Section 1158 of the Corporation Tax Act 2010
(‘Section 1158’). The Company’s objective is to provide long-term growth
by investing in private companies managed by leading private equity managers.
Investments in funds have anticipated lives of approximately 10 years. Direct
Investments are made with an anticipated holding period of between three and
five years.
Financial risk management
The Company’s activities expose it to a variety of financial risks: market
risk (comprising currency risk, interest rate risk and price risk), investment
risk, credit risk and liquidity risk. The Company’s overall risk management
programme focuses on the unpredictability of financial markets and seeks to
minimise potential adverse effects on the Company’s financial performance.
The Board has overall responsibility for managing the risks and the framework
for monitoring and coordinating these risks. The Audit Committee regularly
reviews, identifies and evaluates the risks taken by the Company to allow them
to be appropriately managed. All of the Company’s management functions are
delegated to the Manager which has its own internal control and risk
monitoring arrangements. The Committee makes a regular assessment of these
arrangements, with reference to the Company’s risk matrix. The Company’s
financial risk management objectives and processes used to manage these risks
have not changed from the previous period and the policies are set out below:
Market risk
(i) Currency risk
The Company’s investments are principally in continental Europe, the US and
the UK, and are primarily denominated in euro, US dollars and sterling. There
are also smaller amounts in other European currencies. The Company’s
investments in controlled structured entities are reported in Sterling. The
Company is exposed to currency risk in that movements in the value of sterling
against these foreign currencies will affect the net asset value and the cash
required to fund undrawn commitments. The Board regularly reviews the level of
foreign currency denominated assets and outstanding commitments in the context
of current market conditions and may decide to buy or sell currency or put in
place currency hedging arrangements. No hedging arrangements were in place
during the financial year.
The composition of the net assets of the Company by reporting currency at the
year end is set out below:
Sterling Euro USD Other Total
31 January 2025 £’000 £’000 £’000 £’000 £’000
Investments 1,201,166 81,755 186,623 5 1,469,549
Cash and cash equivalents and other net current assets (139,168) 1,385 618 8 (137,157)
1,061,998 83,140 187,241 13 1,332,392
Sterling Euro USD Other Total
31 January 2024 £’000 £’000 £’000 £’000 £’000
Investments 1,068,115 81,164 146,881 222 1,296,382
Cash and cash equivalents and other net current assets (21,553) 4,504 3,878 12 (13,159)
1,046,562 85,668 150,759 234 1,283,223
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
On a look-through basis to the currency of the portfolio company, the effect
of a 25% increase or decrease in the sterling value of the euro would be a
fall of £71.3m and a rise of £65.1m in the value of shareholders’equity
and on profit after tax at 31 January 2025 respectively (2024: a fall of £74m
and a rise of £56.1m based on 25% increase or decrease).The effect of a 25%
increase or decrease in the sterling value of the US dollar would be a fall of
£158m and a rise of £152.1m in the value of shareholders’ equity and on
profit after tax at 31 January 2025 respectively (2024: a fall of £141.9m and
a rise of £124.4m based on 25% movement). The percentages applied are based
on market volatility in exchange rates observed in prior periods.
(ii) Interest rate risk
The Company’s assets primarily comprise non-interest bearing investments in
funds and non-interest bearing investments in portfolio companies. The fair
values of these investments are not significantly directly affected by changes
in interest rates. The Company’s net debt balance is exposed to interest
rate risk; the financial impact of this risk is currently immaterial.
The Company is indirectly exposed to interest rate risk through the impact of
interest rates on the performance of investments in funds and portfolio
companies as a result of interest rate changes impacting the underlying
manager valuation. This performance impact as a result of interest rate risk
is recognised through the valuation of those investments, which will be
affected by the impact of any change in interest rates on the financial
performance of the underlying portfolio companies and also on any valuation of
those investments for sale. The Company is not able to quantify how a change
in interest rates would impact valuations.
(iii) Price risk
The risk that the value of a financial instrument will change as a result of
changes to market prices is one that is fundamental to the Company’s
objective, which is to provide long-term capital growth through investment in
unquoted companies. The investment Portfolio is continually monitored to
ensure an appropriate balance of risk and reward in order to achieve the
Company’s objective.
The Company is exposed to the risk of change in value of its private equity
investments. For all investments the market variable is deemed to be the price
itself. The table below shows the impact of a 30% increase or decrease in the
valuation of the investment Portfolio. The percentages applied are reasonable
based on the Manager’s view of the potential for volatility in the Portfolio
valuations under stressed conditions.
31 January 2025 31 January 2024
Increase in variable Decrease in variable Increase in variable Decrease in variable
£’000 £’000 £’000 £’000
30% (2024: 30%) movement in the price of investments
Impact on profit after tax 423,339 (370,568) 374,044 (320,217)
A reasonably possible percentage change in relation to the earnings estimates
or Enterprise Value/EBITDA multiples used by the underlying managers to value
the private equity fund investments and co-investments may result in a
significant change in the fair value of unquoted investments.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Investment and credit risk
(i) Investment risk
Investment risk is the risk that the financial performance of the companies in
which the Company invests either improves or deteriorates, thereby affecting
the value of that investment. Investments in unquoted companies whether
indirectly or directly are, by their nature, subject to potential investment
losses. The investment Portfolio is highly diversified in order to mitigate
this risk.
(ii) Credit risk
The Company’s exposure to credit risk arises principally from its investment
in cash deposits. The Company aims to invest the majority of its liquid
portfolio in assets which have low credit risk. The Company’s policy is to
limit exposure to any one investment to 15% of gross assets. This is regularly
monitored by the Manager as a part of its cash management process.
Cash is held on deposit with Royal Bank of Scotland (‘RBS’) and totalled
£3.9m (2024: £9.7m). RBS currently has a credit rating of A1 from Moody’s.
This represented the maximum exposure to credit risk at the balance sheet
date. No collateral is held by the Company in respect of these amounts. None
of the Company’s cash deposits or money market fund balances were past due
or impaired at 31 January 2025 (2024: nil) and as a result of this, no ECL
provision has been recorded.
Liquidity risk
The Company makes commitments to private equity funds in advance of that
capital being invested, typically in illiquid, unquoted companies. These
commitments are in excess of the Company’s total liquidity, therefore
resulting in an overcommitment. When determining the appropriate level of
overcommitment, the Board considers the rate at which commitments might be
drawn down, typically over four to six years, versus the rate at which
existing investments are sold and cash realised. The Company has an
established liquidity management policy, which involves active monitoring and
assessment of the Company’s liquidity position and its overcommitment risk.
This is regularly reviewed by the Board and incorporated into the Board’s
assessment of the viability of the Company. This process incorporates balance
sheet and cash flow projections, including scenarios with varying levels of
Portfolio gains and losses, fund drawdowns and realisations, availability of
the credit facility, exchange rates, and possible remedial action that the
Company could undertake if required in the event of significant Portfolio
declines.
At the year end, the Company had cash and cash equivalents totalling £3.9m
and had access to committed bank facilities of €300m maturing in May 2028,
which is a multi-currency revolving credit facility provided by SMBC and
Lloyds. The key terms of the facility are:
* Upfront cost: 120bps.
* Non-utilisation fees: 115bps per annum.
* Margin on drawn amounts: 300bps per annum.
As at 31 January 2025 the Company’s total financial liabilities amounted to
£143.1m (2024: £25.1m) of payables which were due in less than one year,
which includes accrued balances payable in respect of the credit facility
above.
Movement in financial liabilities arising from financing activities
The following tables sets out the movements in total liabilities held at
amortised cost arising from financing activities undertaken during the year.
2025 2024
£’000 £’000
At 1 February 2024 22,062 67,700
Proceeds from borrowings 139,762 128,109
Repayment of long term borrowings (27,831) (174,954)
Change in capitalisation of bank facility fees 782 1,206
At 31 January 2025 134,775 22,061
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Capital risk management
The Company’s capital is represented by its net assets, which are managed to
achieve the Company’s investment objective. As at the year end, the Company
had net debt of £135.9m (2024: £10.3m).
The Board can manage the capital structure directly since it has taken the
powers, which it is seeking to renew, to issue and buy back shares and it also
determines dividend payments. The Company is subject to externally imposed
capital requirements with respect to the obligation and ability to pay
dividends by Section 1159 of the Corporation Tax Act 2010 and by the Companies
Act 2006, respectively. Total equity at 31 January 2025, the composition of
which is shown on the balance sheet, was £1,332.4m (2024: £1,283.2m).
Fair values estimation
IFRS 13 requires disclosure of fair value measurements of financial
instruments categorised according to the following fair value measurement
hierarchy:
* Quoted prices (unadjusted) in active markets for identical assets or
liabilities (Level 1).
* Inputs other than quoted prices included within level 1 that are observable
for the asset or liability, either directly (that is, as prices) or indirectly
(that is, derived from prices) (Level 2).
* Inputs for the asset or liability that are not based on observable market
data (that is, unobservable inputs) (Level 3).
The valuation techniques applied to level 3 assets are described in note 1(c)
of the financial statements. No investments were categorised as level 1 or
level 2.
The Company’s policy is to recognise transfers into and transfers out of
fair value hierarchy levels at the end of the reporting year when they are
deemed to occur.
The sensitivity of the Company’s investments to a change in value is
discussed on page 51.
The following table presents the assets that are measured at fair value at 31
January 2025 and 31 January 2024:
31 January 2025
Level 1 Level 2 Level 3 Total
£’000 £’000 £’000 £’000
Investments held at fair value
Unquoted investments – indirect — — 150,987 150,987
Unquoted investments – direct — — 154,242 154,242
Quoted investments – direct — — — —
Subsidiary undertakings — — 1,164,320 1,164,320
Total investments held at fair value — — 1,469,549 1,469,549
31 January 2024
Level 1 Level 2 Level 3 Total
£’000 £’000 £’000 £’000
Investments held at fair value
Unquoted investments – indirect — — 136,473 136,473
Unquoted investments – direct — — 123,823 123,823
Quoted investments – direct — — — —
Subsidiary undertakings — — 1,036,085 1,036,085
Total investments held at fair value — — 1,296,381 1,296,381
All unquoted and quoted investments are valued at fair value in accordance
with IFRS 13. The Company has no quoted investments as at 31 January 2025;
quoted investments held by subsidiary undertakings are reported within Level
3.
Investments in Level 3 securities are in respect of private equity fund
investments and co-investments. These are held at fair value and are
calculated using valuations provided by the underlying manager of the
investment, with adjustments made to the statements to take account of cash
flow events occurring after the date of the manager’s valuation, such as
realisations or liquidity adjustments.
The following tables present the changes in Level 3 instruments for the year
to 31 January 2025 and 31 January 2024.
31 January 2025 Unquoted investments (indirect) at fair value through profit or loss £’000 Unquoted investments (direct) at fair value through profit or loss £’000 Subsidiary undertakings £’000 Total £’000
Opening balances 136,473 123,823 1,036,086 1,296,382
Additions 18,124 16,020 151,292 185,436
Disposals (16,076) (4,138) (125,769) (145,983)
Gains and losses recognised in profit or loss 14,524 16,479 102,711 133,714
Closing balance 153,045 152,184 1,164,320 1,469,549
31 January 2024 Unquoted investments (indirect) at fair value through profit or loss £’000 Unquoted investments (direct) at fair value through profit or loss £’000 Subsidiary undertakings £’000 Total £’000
Opening balances 158,896 110,282 1,079,897 1,349,075
Additions 14,933 10,248 116,988 142,169
Disposals (37,167) (3,590) (195,300) (236,057)
Gains and losses recognised in profit or loss (188) 6,883 34,500 41,194
Closing balance 136,474 123,823 1,036,085 1,296,381
18 RELATED PARTY TRANSACTIONS
Significant transactions between the Company and its subsidiaries are shown
below:
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Subsidiary Nature of transaction Year ended 31 January 2025 £’000 Year ended 31 January 2024 £’000
ICG Enterprise Trust Limited Partnership Increase in amounts owed to subsidiaries — —
(Decrease) in amounts owed by subsidiaries (8,689) (102)
Income allocated — —
ICG Enterprise Trust (2) Limited Partnership Increase in amounts owed to subsidiaries (2,956) 11,420
(Decrease) in amounts owed by subsidiaries — —
Income allocated (169) 151
ICG Enterprise Trust Co-investment LP Increase in amounts owed by subsidiaries 33,229 (10,416)
Income allocated 2,127 6,681
ICG Enterprise Holdings LP Increase in amounts owed to subsidiaries — (45,725)
Income allocated 4,224 6,819
ICG Morse Partnership LP Increase in amounts owed by subsidiaries — (14,513)
Decrease in amounts owed to subsidiaries — —
Income allocated — —
ICG Lewis Partnership LP (Decrease) in amounts owed by subsidiaries 687 1,820
Increase in amounts owed by subsidiaries — —
Income allocated — —
ICG Enterprise Trust Limited Partnership transferred its remaining assets to
ICG Enterprise Trust PLC during the year ended 31 January 2025. It will be
dissolved during the year ended 31 January 2026 and will cease to be a
subsidiary at that time.
For the purpose of IAS 24 Related Party Disclosures, key management personnel
comprised the Board of Directors.
Remuneration in the year (audited) Fees Expenses Total
Name 2025 £’000 2024 £’000 2025 £’000 2024 £’000 2025 £’000 2024 £’000
Jane Tufnell 74 71 — 74 71
Alastair Bruce 60 58 — — 60 58
David Warnock 59 46 — 59 46
Gerhard Fusenig 48 46 3 2 51 49
Adiba Ighodaro 48 46 — — 48 46
Janine Nicholls 48 46 — — 48 46
Total 337 313 3 2 340 316
Amounts owed by/to subsidiaries represent the Company’s loan account
balances with those entities, to which the Company’s share of drawdowns and
distributions in respect of those entities are credited and debited
respectively.
NOTES TO THE FINANCIAL STATEMENTS CONTINUED
Amounts owed by subsidiaries Amounts owed to subsidiaries
Subsidiary 31 January 2025 £’000 31 January 2024 £’000 31 January 2025 £’000 31 January 2024 £’000
ICG Enterprise Trust Limited Partnership — — (492) 8,197
ICG Enterprise Trust (2) Limited Partnership — — 31,372 34,328
ICG Enterprise Trust Co-Investment LP 273,555 240,326 — —
ICG Enterprise Holdings LP — — — —
ICG Morse Partnership LP — — — —
ICG Lewis Partnership LP 8,569 7,881 — —
The Company and its subsidiaries’ total shares in funds and co-investments
managed by the Company’s Manager are:
Year ended 31 January 2025 Year ended 31 January 2024
Fund/Co-investment Remaining commitment £’000 Fair value investment £’000 Remaining commitment £’000 Fair value investment £’000
ICG MXV Co-Investment 8,361 32,728 217 31,658
ICG Strategic Equity Fund III 10,727 31,043 10,942 39,374
ICG Europe VII 6,082 30,721 6,541 35,021
ICG Ludgate Hill (Feeder B) SCSp 13,591 23,814 13,860 24,366
ICG Europe VIII 14,339 23,640 25,901 10,746
ICG Augusta Partners Co-Investor 17,775 20,469 17,365 15,533
ICG Ludgate Hill (Feeder) III A Porsche SCSp 5,691 17,995 4,652 21,104
ICG Newton Co-Investment 393 17,808 393 17,909
ICG Progress Co-Investment 421 17,265 577 15,156
ICG Vanadium Co-Investment 246 16,180 251 14,209
ICG Ludgate Hill (Feeder) II Boston SCSp 5,392 16,030 5,267 14,721
ICG Match Co-Investment 132 15,253 129 15,403
ICG Colombe Co-investment 1,810 13,795 1,678 12,221
ICG Europe Mid-Market Fund 5,524 13,494 5,476 13,819
ICG LP Secondaries Fund I LP 41,146 12,175 34,811 21,980
ICG Cheetah Co-Investment 635 11,123 669 11,570
CX VIII Co-Investment 167 9,076 171 8,996
ICG Asia Pacific Fund III 2,523 8,706 2,634 8,436
ICG Dallas Co-Investment 1,240 8,172 1,280 8,245
ICG Strategic Equity V 36,868 7,101 19,704 895
ICG Strategic Equity IV 7,055 32,851 10,385 28,029
ICG Sunrise Co-Investment 75 5,840 76 5,402
ICG Crown Co-Investment 96 5,492 122 4,817
ICG Recovery Fund 2008 B1 846 4,954 862 4,545
ICG Strategic Secondaries Fund II 16,938 4,853 16,547 10,052
ICG Holiday Co-Investor I 286 3,748 285 2,655
ICG North American Private Debt Fund II 2,097 3,061 1,682 5,467
ICG Europe VI 4,013 2,814 4,311 5,719
ICG Holiday Co-Investor II 199 2,775 197 1,966
ICG Europe Mid-Market II 19,245 1,534 21,316 (263)
ICG Europe V 545 757 555 808
ICG Cross Border 182 273 178 5,555
ICG Diocle Co-Investment 145 81 148 98
ICG Velocity Partners Co-Investor 650 18 635 —
ICG European Fund 2006 B1 480 15 489 28
ICG Topvita Co-Investment 687 — 700 —
ICG Trio Co-Investment 36 — 37 7,988
Ambassador Theatre Group — — — 14,177
Total 226,638 415,652 211,043 438,410
At the balance sheet date the Company has fully funded its share of capital
calls due to ICG-managed funds in which it is invested.
19 Post balance sheet events
On 2 April 2025, the Company announced the completion of a secondary sale of
primary fund interests generating £62m net proceeds and releasing undrawn
commitments of £10m. On 30 April 2025 the Company cancelled its Treasury
shares (see note 14). 9,358,808 shares were cancelled.
GLOSSARY
Term Short form Definition
Alternative Performance Measures APMs Alternative Performance Measures are a term defined by the European Securities and Markets Authority as “financial measures of historical or future performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework”. APMs are used in this report if considered by the Board and the Manager to be the most relevant basis for shareholders in assessing the overall performance of the Company and for comparing the performance of the Company to its peers, taking into account industry practice. Definitions and
reconciliations to IFRS measures are provided in the main body of the report or in this Glossary, where appropriate.
Buyback impact on NAV per Share Buyback impact on NAV per Share is calculated by comparing the NAV per Share with an adjusted NAV per Share as follows:
Year ended 31 January 2025 Since inception (Oct. 22)
Opening number of shares 67,190,867 68,523,055 A
Number of shares bought back in period 2,912,675 4,244,863
Closing number of shares 64,278,192 64,278,192 B
31 January 2025 NAV £1,332m £1,332m C
Add back cash invested in buybacks £36m £51m
31 January 2025 NAV + cash invested in buybacks £1,368m £1,383m D
31 January 2025 NAV per Share 2,072.9p 2,072.9p E (C/B)
Pro forma NAV per share excluding buybacks 2,036.4p 2,018.8p F (D/A)
Impact of buybacks 36.5p 54.1p G (E-F)
NAV per Share accretion from buybacks 1.8% 2.7% G/F
Note
:
scen
ario
excl
udin
g
buyb
ack
does
not
incl
ude
any
cash
impa
ct
of
divi
dend
s
that
woul
d
have
been
paid
to
hold
ers
of
thos
e
shar
es
had
the
buyb
ack
not
been
unde
rtak
en
Carried Interest Carried interest is equivalent to a performance fee. This represents a share of the profits that will accrue to the underlying private equity managers, after achievement of an agreed Preferred Return.
Cash drag Cash drag is the negative impact on performance arising as a result of the allocation of a portion of the entity’s assets to cash.
Co-investment Co-investment is a Direct Investment in a company alongside a private equity fund.
Co-investment Incentive Scheme Accrual Co-investment Incentive Scheme Accrual represents the estimated value of interests in the Co-investment Incentive Scheme operated by the subsidiary partnerships of the Company.
Commitment Commitment represents the amount of capital that each investor agrees to contribute to a fund or a specific investment.
Compound Annual Growth Rate CAGR The rate of return that would be required for an investment to grow from its beginning balance to its ending balance, assuming the profits were reinvested at the end of each period of the investment's life span.
Deployment Please see ‘Total new investment’.
Direct Investment An investment in a portfolio company held directly, not through a private equity fund. Direct Investments are typically co-investments with a private equity fund.
Discount Discount arises when the Company’s shares trade at a price below the Company’s NAV per Share. In this circumstance, the price that an investor pays or receives for a share would be less than the value attributable to it by reference to the underlying assets. The Discount is the difference between the share price and the NAV, expressed as a percentage of the NAV. For example, if the NAV was 100p and the share price was 90p, the Discount would be 10%.
Drawdowns Drawdowns are amounts invested by the Company when called by underlying managers in respect of an existing Commitment.
EBITDA Stands for earnings before interest, tax, depreciation and amortisation, which is a widely used profitability measure in the private equity industry.
Enlarged Perimeter The aggregate Portfolio value of the Top 30 Companies and as many of the managers from within the Top 30 funds as practicable.
Enterprise Value EV Enterprise Value is the aggregate value of a company’s entire issued share capital and Net Debt.
Exclusion List The Exclusion List defines the business activities which are excluded from investment.
FTSE All-Share Index Total Return The change in the level of the FTSE All-Share Index, assuming that dividends are re-invested on the day that they are paid.
Full Exits Full Exits are exit events (e.g., trade sale, sale by public offering, or sale to a financial buyer) following which the residual exposure to an underlying company is zero or immaterial; this does not include Fund Disposals. See ‘Fund Disposals’.
Fund Disposals Fund Disposals are where the Company receives sales proceeds from the full or partial sale of a fund position within the secondary market.
General Partner GP The General Partner is the entity managing a private equity fund. This is commonly referred to as the manager.
Hedging Hedging is an investment technique designed to offset a potential loss on one investment by purchasing a second investment that is expected to perform in the opposite way.
Initial Public Offering IPO An Initial Public Offering is an offering by a company of its share capital to the public with a view to seeking an admission of its shares to a recognised stock exchange.
Internal Rate of Return IRR Internal Rate of Return is a measure of the rate of return received by an investor in a fund. It is calculated from cash drawn from and returned to the investor, together with the residual value of the investment.
Investment Period Investment Period is the period in which funds are able to make new investments under the terms of their fund agreements, typically up to five years after the initial Commitment.
Last Twelve Months LTM Last Twelve Months refers to the timeframe of the immediately preceding 12 months in reference to financial metrics used to evaluate the Company’s performance.
Limited Partner LP The Limited Partner is an institution or individual who commits capital to a private equity fund established as a Limited Partnership. These funds are generally protected from legal actions and any losses beyond the original investment.
Limited Partnership A Limited Partnership includes one or more General Partners, who have responsibility for managing the business of the partnership and have unlimited liability, and one or more Limited Partners, who do not participate in the operation of the partnership and whose liability is ordinarily capped at their capital and loan contribution to the partnership. In typical fund structures, the General Partner receives a priority share ahead of distributions to Limited Partners.
Net Asset Value per Share NAV per Share Net Asset Value per Share is the value of the Company’s net assets attributable to one Ordinary share. It is calculated by dividing ‘shareholders’ funds’ by the total number of ordinary shares in issue. Shareholders’ funds are calculated by deducting current and long-term liabilities, and any provision for liabilities and charges, from the Company’s total assets.
Net Debt Net Debt is calculated as the total short-term and long-term debt in a business, less cash and cash equivalents.
Ongoing charges Ongoing Charges are calculated in line with guidance issued by the Association of Investment Companies (‘AIC’) and capture management fees and expenses, excluding finance costs, incurred at the Company level only. The calculation does not include the expenses and management fees incurred by any underlying funds.
31 January 2025 Total per income statement £'000 Amount excluded from AIC Ongoing Charges £'000 Included Ongoing Charges £000
Management fees 16,175 — 16,175
General expenses 1,500 165 1,665
Finance costs 9,354 (9,354) —
Total 27,029 (9,189) 17,840
Total Ongoing Charges 17,840
Average NAV 1,294,186
Ongoing Charges as % of NAV 1.38%
31 January 2024 Total per income statement £'000 Amount excluded from AIC Ongoing Charges £'000 Included Ongoing Charges £000
Management fees 16,148 — 16,148
General expenses 1,773 (209) 1,564
Finance costs 8,152 (8,152) —
Total 26,073 (8,362) 17,712
Total Ongoing Charges 17,712
Average NAV 1,291,759
Ongoing Charges as % of NAV 1.37%
Included within General expenses above are £(0.2)m (credit) (2024: £0.2m) of other expenses which are non-recurring and are excluded from the Ongoing Charges.
Other Net Liabilities Other Net Liabilities at the aggregated Company level represent net other liabilities per the Company’s balance sheet. Net other liabilities per the balance sheet of the subsidiaries include amounts payable under the Co-investment Incentive Scheme Accrual.
Overcommitment Overcommitment refers to where private equity fund investors make Commitments exceeding the amount of liquidity immediately available for investment. When determining the appropriate level of Overcommitment, careful consideration needs to be given to the rate at which Commitments might be drawn down, and the rate at which realisations will generate cash from the existing Portfolio to fund new investment.
Portfolio Portfolio represents the aggregate of the investment Portfolios of the Company and of its subsidiary Limited Partnerships. This APM is consistent with the commentary in previous annual and interim reports. The Board and the Manager consider that disclosing our Portfolio assists shareholders in understanding the value and performance of the underlying investments selected by the Manager. It is shown before the Co-investment Incentive Scheme Accrual to avoid being distorted by certain funds and Direct Investments on which ICG Enterprise Trust Plc does not incur these costs (for example, on funds managed by ICG plc). Portfolio is related to the NAV, which is the value attributed to our shareholders, and which also incorporates the Co-investment Incentive Scheme Accrual as well as the
value of cash and debt retained on our balance sheet. The value of the Portfolio at 31 January 2025 is £1,523.1m (31 January 2024: £1,349.0m).
31 January 2025 £m IFRS Balance sheet fair value Net assets of subsidiary limited partnerships Co-investment Incentive Scheme Accrual Total Company and subsidiary Limited Partnership
Investments (1) 1,469.5 (0.3) 53.9 1,523.1
Cash 3.9 — — 3.9
Other Net Liabilities (141.0) 0.3 (53.9) (194.6)
Net assets 1,332.4 — — 1,332.4
31 January 2024 £m IFRS Balance sheet fair value Balances receivable from subsidiary Limited Partnerships Co-investment Incentive Scheme Accrual Total Company and subsidiary Limited Partnership
Investments (1) 1,296.4 (1.9) 54.4 1,349.0
Cash 9.7 — — 9.7
Other Net Liabilities (22.9) 1.9 (54.4) (75.5)
Net assets 1,283.2 — — 1,283.2
(1)Investments as reported on the IFRS balance sheet at fair value comprise the total of assets held by the Company and the net asset value of the Company’s investments in the subsidiary Limited Partnerships.
Portfolio Return on a Local Currency Basis Portfolio Return on a Local Currency Basis represents the change in the valuation of the Company’s Portfolio before the impact of currency movements and Co-investment Incentive Scheme Accrual. The Portfolio return of 10.2% is calculated as follows:
£m 31 January 2025 31 January 2024
Income, gains and losses on Investments 142.0 125.3
Foreign exchange gains and losses included in gains and losses on investments 5.4 (38.6)
Incentive accrual valuation movement (9.3) (3.7)
Total gains on Portfolio investments excluding impact of foreign exchange 138.1 83.1
Opening Portfolio valuation 1,349.0 1,406.4
Portfolio Return on a Local Currency Basis 10.2% 5.9%
Term Short form Definition
Portfolio Company Portfolio Company refers to an individual company in an investment portfolio.
Primary A Primary Investment is a Commitment to a private equity fund.
Quoted Company A Quoted Company is any company whose shares are listed or traded on a recognised stock exchange.
Realisation Proceeds Realisation Proceeds are amounts received in respect of underlying realisation activity from the Portfolio and exclude any inflows from the sale of fund positions via the secondary market.
Realisations - Multiple to Cost Realisations - Multiple to Cost is the average return from Full Exits from the Portfolio in the period on a primary investment basis, weighted by cost.
£m 31 January 2025 31 January 2024
Realisation Proceeds from Full Exits in the year-to-date 73.7 100.8
Cost 35.9 28.8
Average return Multiple to Cost 2.9x 3.5x
Realisations – Uplift To Carrying Value Realisations – Uplift To Carrying Value is the aggregate uplift on Full exits from the Portfolio in the period excluding publicly listed companies that were exited via sell downs of their shares.
£m 31 January 2025 31 January 2024
Realisation Proceeds from Full Exits in the year-to-date 73.7 100.8
Prior Carrying Value (at previous quarterly valuation prior to exit) 62.0 89.2
Realisations – Uplift To Carrying Value 19.0% 29.5%
Secondary Investments Secondary Investments occur when existing private equity fund interests and Commitments are purchased from an investor seeking liquidity.
Share Price Total Return Share Price Total Return is the change in the Company’s share price, assuming that dividends are re-invested on the day that they are paid.
Total New Investment Total New Investment is the total of direct Co-investment and fund investment Drawdowns in respect of the Portfolio. In accordance with IFRS 10, the Company’s subsidiaries are deemed to be investment entities and are included in subsidiary investments within the financial statements. Movements in the cash flow statement within the financial statements reconcile to the movement in the Portfolio as follows:
£m 31 January 2025 31 January 2024
Purchase of Portfolio investments per cash flow statement 34.1 25.2
Purchase of Portfolio investments within subsidiary investments 152.2 111.6
Return of cost/expenses (4.9) 0.0
Total New Investment 181.4 136.7
Term Short form Definition
Total Proceeds Total Proceeds are amounts received by the Company in respect of the Portfolio, which may be in the form of capital proceeds or income such as interest or dividends. In accordance with IFRS 10, the Company’s subsidiaries are deemed to be investment entities and are included in subsidiary investments within the financial statements.
£m 31 January 2025 31 January 2024
Sale of Portfolio investments per cash flow statement 20.0 40.6
Sale of Portfolio investments, interest received, and dividends received within subsidiary investments 125.8 195.3
Interest income per cash flow statement 0.5 1.7
Dividend income per cash flow statement 0.5 0.8
Other income per cash flow statement 0.1 —
Return of invested cost 4.0 0.0
Total Proceeds 150.8 238.6
Fund Disposals — (67.6)
Realisation Proceeds 150.8 171.0
Total Return The change in the Company’s Net Asset Value per Share, assuming that dividends are re-invested at the end of the quarter in which the dividend was paid.
Undrawn Commitments Undrawn Commitments are Commitments that have not yet been drawn down (please see ‘Drawdowns’).
Unquoted Company An Unquoted Company is any company whose shares are not listed or traded on a recognised stock exchange.
Valuation Date The date of the valuation report issued by the underlying managerRecent news on ICG Enterprise Trust
See all newsREG-Voting Rights and Capital
AnnouncementREG-Transaction in Own Shares
AnnouncementREG-Transaction in Own Shares
AnnouncementREG-Transaction in Own Shares
AnnouncementREG-Transaction in Own Shares
Announcement